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Morphological and Functional Evidence of Sexual Dimorphism in the Retrochiasmatic 
Area Population of NK3R-containing Neurons in Sheep 
 
The neuropeptides neurokinin B (NKB) and kisspeptin are critical for fertility in humans and 
potent stimulators of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) 
secretion in primates and sheep. We previously demonstrated that administration of a selective 
NKB receptor (NK3R) agonist, senktide, within the retrochiasmatic area (RCh) resulted in surge-
like release of LH and increased cellular expression of kisspeptin neurons in the arcuate nucleus 
(ARC) of female lambs. Based on these findings, we concluded that NKB-responsive neurons in 
the RCh act to stimulate GnRH secretion by inducing kisspeptin release from neurons in the ARC.  
 
One important characteristic of the LH surge in many species is that it is sexually dimorphic, 
occurring in females but not in males. As such, we tested if the response to local administration of 
senktide is sexually dimorphic and examined sex differences in NKB and NK3R expression in 
ewe-lambs and wethers (rams that were castrated three weeks after birth). In females, senktide-
containing microimplants placed in the RCh produced a significant increase in LH concentrations 
that lasted for at least 8 hours after the start of treatment, while a much shorter increase (~2 hours) 
was seen in males. Based on previous work, as expected, there were more NKB-containing neurons 
in the ARC of females than males. Interestingly, there was a similar sexual dimorphism in numbers 
of NK3R-containing neurons in the RCh and preoptic area (POA), NKB-containing close contacts 
onto these RCh NK3R neurons, and NKB-positive fibers in this region. These data demonstrate 
that there are both functional and morphological sex differences in NKB-NK3R signaling in the 
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RCh and raise the possibility that this dimorphism contributes to the sex-dependent ability of 
estradiol to induce an LH surge in female sheep.  
 
To determine if a neuroanatomical basis exists for this sexual dimorphism in acutely-
gonadectomized animals, we characterized the expression of NK3R-, NKB-, and kisspeptin-
containing neurons in the hypothalamus. In the ARC, the total number of NKB or kisspeptin 
neurons was higher in females than males, but no difference was observed in the percentage of 
NKB or kisspeptin cells that colocalized with NK3R. There was no difference in numbers of 
NK3R-containing neurons in the POA between females and males, however, a significantly greater 
number of NK3R-ir cells was observed for females in the RCh. These data provide evidence for a 
sexual dimorphism in the neurological control of the LH surge and further indicate that the sexual 
dimorphism in ARC kisspeptin neurons is due to the organizational actions of gonadal steroids.  
 
The true phenotype of NK3R-containing neurons in the RCh has yet to be elucidated. However, 
one potential neurotransmitter coexpressed in these neurons is galanin. In a preliminary study in 
sheep, it was discovered that 20-30% of NK3R-positive neurons contain galanin. Galanin 
stimulates LH secretion in several species and its expression has been shown to be sexually 
dimorphic in rodents. We investigated the distribution of galanin/NK3R neurons in the RCh to 
determine if this population is sexually dimorphic in sheep. Furthermore, we assessed the effect of 
central galanin administration on tonic LH secretion and galantide (a non-specific galanin receptor 
antagonist) infusion during the breeding season and in anestrous ewes to determine the influence 
of blocking galanin input on both tonic and surge LH secretion in this species. The number of 
NK3R-ir cells in the RCh was greater in females than in males. However, no difference was 
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observed in the number of galanin-immunoreactive cells found within the RCh. Furthermore, no 
significant difference was observed in the percentage of galanin/NK3R co-expression between 
sexes. In the assessment of galanin effects on LH secretion, a minor stimulatory effect of galanin 
was observed on LH pulse frequency (P = 0.07) during anestrous and on LH pulse amplitude 
during the breeding season (5 nmole dose; P = 0.06). During an estrogen-induced surge, galantide 
infusion resulted in a minor, not significant, inhibitory effect on surge amplitude (approximately 
by 25%) in animals during the breeding season. These results tentatively support a 
neuroanatomical framework for galanin activity and provide preliminary evidence that 
endogenous galanin may contribute to LH secretion in sheep, however, more pharmacological 
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Figure 1.1. Schematic illustration of hormone secretory profiles across the follicular phase in the 
ew.  
 
Figure 1.2. Model for control of KNDy neural activity proposed to drive episodic GnRH secretion  
 
Figure 1.3. Schematic representation of connectivity between neurons implicated in the luteinizing 
hormone surge in sheep 
 
Figure 1.4. Timing of puberty in spring-born male and female lambs, and corresponding changes 
in LH secretion, in relation to age and photoperiod 
 
Figure 1.5. Effects of androgen treatment in utero on external genitalia, neuroendocrine sexual 
maturation, and the LH surge in female lambs 
 
Figure 2.1. Effect of senktide-containing microimplants on LH secretion during an artificial 
follicular phase in female and male sheep 
 
Figure 2.2. Mean LH concentrations after administration of senktide-containing microimplants 
within the RCh 
 
Figure 2.3. NK3R immunoreactivity in the POA during an estrogen-induced LH surge in female 
and male sheep 
 
Figure 2.4. NK3R immunoreactivity in the RCh during an estrogen-induced LH surge in female 
and male sheep 
 
Figure 2.5. NKB immunoreactivity in the ARC during an estrogen-induced LH surge in female 
and male sheep 
 
Figure 2.6. NKB and NK3R immunoreactivity in the RCh during an estrogen-induced LH surge 
in female and male sheep 
 
Supplemental Figure 2.1. Steroid-induced suppression of LH secretion in wethers 
 
Figure 3.1. Representative LH concentrations over time for a female sheep compared to that of a 
male sheep after the administration of estrogen implants 
 
Figure 3.2. Mean LH concentrations for acutely-castrated female and male sheep during exposure 





Figure 3.3. NK3R immunoreactivity in the POA and RCh during an estrogen-induced LH surge 
in acutely-castrated female and male sheep 
 
Figure 3.4. NKB, kisspeptin, and NK3R immunoreactivity in the ARC during an estrogen-induced 
LH surge in acutely-castrated female and male sheep 
 
Figure 3.5. NKB and NK3R immunoreactivity in the RCh during an estrogen-induced LH surge 
in acutely-castrated female and male sheep 
 
Figure 4.1. Galanin and NK3R immunoreactivity in the RCh during an estrogen-induced LH surge 
in female and male sheep 
 
Figure 4.2. Galanin and CTβ immunoreactivity in the RCh of female sheep 
 
Figure 4.3. Effect of icv injection of galanin on LH secretion in ovary-intact anestrous ewes 
 
Figure 4.4. Effect of icv injection of galanin on LH secretion in ovary‐ intact breeding season 
ewes 
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REVIEW OF LITERAURE 
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1. The Reproductive Axis 
 
Appropriate control of reproductive function requires communication from the brain, the pituitary 
gland, and the gonads. The brain controls the hypothalamic-pituitary-gonadal (HPG) axis via the 
release of the hypothalamic decapeptide gonadotropin-releasing hormone (GnRH) from neurons 
spread throughout the preoptic area (POA) and mediobasal hypothalamus (MBH). GnRH-
containing neurons send axonal projections to the median eminence (ME) where, after release, 
GnRH travels through the hypophyseal portal system of blood vessels that connects the ME with 
the anterior pituitary and gonadotropic cells that exist therein. Upon stimulation, gonadotropic 
cells are capable of releasing both luteinizing hormone (LH) and follicle-stimulating hormone 
(FSH). Gonadotropin release from the anterior pituitary is critical for appropriate reproductive 
function and fertility in both males and females. These hormones are essential for processes related 
to gametogenesis (spermatogenesis in males and oogenesis in females) and steroidogenesis 
(synthesis and release of gonadal steroid hormones testosterone in males, progesterone in females, 
and estrogen in males and females, respectively). In females, steroid hormone release from the 
gonads participates in the active control of neuroendocrine reproductive function by way of 
feedback loops that modulate GnRH and LH/FSH secretion throughout the course of an estrous 
cycle or menstrual cycle (primates).  
 
2. Reproductive Cycles  
 
After puberty, females enter a period of life-long reproductive cyclicity – albeit with interruptions 
such as pregnancy, nursing, menopause (primates), and season in some species – that allows for 
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multiple opportunities to copulate, become pregnant, and rear offspring. Generally speaking, 
females can be characterized to exhibit one of three types of estrous cyclicity: polyestrus, 
seasonally polyestrus, and monoestrus. Polyestrous females, such as cattle, swine, some species of 
rodents, and primates display consistent and uniform reproductive cycles that occur throughout the 
entire year. These females can become pregnant at any time without regard to season. Similarly, 
seasonally polyestrus females, such as sheep, goats, certain rodents species such as hamsters, and 
mares, display consistent and uniform series of reproductive cycles that occur within a specific 
season of the year; short-day breeding females (sheep and goats) begin to cycle during shortening 
days of the fall, while long-day breeding females (hamsters and mares) begin to cycle during 
lengthening days of the summer. This type of reproductive cycle combines with the respective 
lengths of gestation to permit birth of young at a time of the year that is optimal for survival. Lastly, 
and in contrast to polyestrus females, monoestrus females, such as dogs, are characterized as 
having only one estrous cycle per year. In contrast to females, male reproduction (i.e. sperm 
production) in most mammals, remains generally consistent throughout the year due to adequate 
secretion of GnRH from the hypothalamus, FSH and LH from the anterior pituitary, and steroids 
(estradiol and testosterone) from the testes to support fertility.  
 
The estrous/menstrual cycle consists of two major phases named after the dominant structure on 
the ovary during each phase of the cycle. The follicular phase is the period of time between corpora 
lutea regression and ovulation. In most species, the follicular phase is relatively short, covering 
approximately 20% of the entire estrous cycle. The dominant ovarian structures at this time are 
large, growing antral follicles that are preparing for ovulation and secreting the steroid hormone 
estradiol. During the follicular phase, four significant events take place within the HPG axis: LH 
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and FSH release from the anterior pituitary, follicular preparation for ovulation, sexual receptivity 
(estrus), and ovulation. During the early follicular phase, GnRH pulse frequency increases due to 
low levels of circulating progesterone, causing the release of both LH and FSH from the anterior 
pituitary. Once released into the systemic circulation, these gonadotropins stimulate follicular 
development and the release of low levels of estradiol from growing follicles, which continues 
until this steroid reaches a level high enough to stimulate surge secretion of GnRH from the 
hypothalamus, and subsequently LH from the anterior pituitary and estrous behavior. The 
increasingly high level of estradiol that results in estrous behavior and surge secretion of GnRH 
and LH is then shortly followed by the first meiotic division of the oocyte and ovulation. After 
ovulation, the theca interna and granulosa cells of the follicle undergo luteinization; a process 
governed by LH. The functional corpus luteum (CL) consists of large luteal cells derived from 
granulosa cells and small luteal cells derived from thecal cells. The CL becomes the dominant 
ovarian structure during the luteal phase and secretes the steroid hormone progesterone. Increasing 
levels of progesterone will begin to inhibit GnRH pulse frequency, prevent behavioral estrus, and 
thwart any further LH surges. Thus, the luteal phase is the period of time from ovulation and 
formation of the CL to corpora lutea regression. In many species, the luteal phase is much longer 
than the follicular, lasting approximately 80% of the entire estrous cycle. If pregnancy does not 
occur, luteolysis ensues, resulting in cessation of progesterone secretion, structural regression of 
the CL, and removal of progesterone negative feedback on GnRH secretion, ushering in a new 
follicular phase. In sheep, a 16- to 17-day estrous cycle will have a 2- to 3-day follicular phase and 
a 13- to 14-day luteal phase. The delineation between a follicular phase and subsequent luteal 






3. Patterns of GnRH, LH, and FSH Secretion 
 
The intimate relationship of GnRH and LH secretion – i.e., changes in LH release patterns reflect 
changes in GnRH release patterns – allows for LH secretion to act as a reliable and easily 
measurable index of GnRH secretion. Considerable progress has been made into understanding 
the dynamic release patterns of GnRH, and subsequently LH, due to the size and accessibility of 
the portal microcirculation in sheep (1). Moreover, FSH, working in conjunction with LH, serves 
a particular role in promoting folliculogenesis.  
 
Two modes of secretion of GnRH exist: tonic and surge secretion. Tonic GnRH secretion is 
episodic and drives low level LH pulses throughout the estrous cycle that are important for 
steroidogenesis. A robust and prolonged elevation of GnRH (surge GnRH secretion), triggered by 
high levels of circulating estrogen late in the follicular phase, is closely followed by a surge of LH. 
The control of pulsatile or surge-like GnRH secretion occurs via negative or positive estrogen 
feedback, respectively, acting at different neuroanatomical sites throughout the POA and MBH. 
Regulation of tonic GnRH secretion by estrogen negative feedback has been identified as occurring 
in the MBH in sheep (2), rats (3), and primates (4). In contrast, control of surge GnRH secretion 
by estrogen positive feedback has been identified as occurring in the MBH in sheep (2) and 
primates (5), and the anteroventral periventricular region (AVPV) and adjacent areas in rodents 
(6–8). Because GnRH neurons do not contain the steroid receptors that mediate the actions of 
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estrogen (9), progesterone (10), or androgen (11), an indirect route for steroid feedback is likely 
utilized. Some of these intermediates will be discussed in detail in later sections.  
 
 
Tonic Secretion of GnRH and LH 
 
Adequate pulsatile secretion of GnRH is essential for normal reproductive function (12).  
Throughout the estrous cycle in females, and over the course of a lifespan in males, LH is regularly 
secreted from the anterior pituitary in a pulsatile manner in response to pulsatile GnRH secretion 
from the hypothalamus (13). The intermittent release pattern of GnRH comprising each pulse is 
driven by a coordinated network of cells located in the hypothalamus, termed the GnRH pulse 
generator (14).  
 
In male sheep, testicular testosterone acts to regulate GnRH and LH pulse frequency and amplitude 
with no consistent changes in pulse patterns over the course of a lifetime (15). In females, however, 
the frequency and amplitude of GnRH and LH pulses vary over the course of an estrous cycle due  
to feedback regulation by ovarian steroids (13). During the breeding season, estrogen and 
progesterone act to suppress GnRH pulse amplitude and frequency, respectively, and these actions 
are mediated by ERα and PR-dependent mechanisms via signaling in the hypothalamus in females 
(16). During the mid-luteal phase, when progesterone levels are high, GnRH and LH pulse 
frequency is low, while pulse amplitude is high. After luteolysis – regression of the CL and rapid 
decline in progesterone levels – GnRH and LH pulse frequency increases, while pulse amplitude 
begins to decrease (17). Generally speaking, pulse frequency is high during the follicular phase of 
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the estrous cycle, decreases to a nadir during the luteal phase, and then progressively increases 
throughout the next follicular phase. Because changes in LH pulse amplitude are not as drastic as 
changes in LH pulse frequency, mean concentrations of LH correlate better with the prevailing 
state of pulse frequency in female sheep (17).  
 
Surge Secretion of GnRH and LH  
 
The second mode of GnRH and LH secretion occurs toward the end of the follicular phase in 
response to estrogen positive feedback from the ovary and results in a transient, massive discharge 
of LH from the anterior pituitary (18,19); an event that causes ovulation – the release of a mature 
egg from the ovary – and correlates with a well-defined period of sexual receptivity (estrous 
behavior) in most species. During a surge, GnRH concentrations are 20- to 40- fold higher than 
that of basal GnRH levels, while LH concentrations rise to levels that are nearly 100 times that of 
basal LH concentration. In sheep, the LH surge lasts approximately 12 hours, with the length of 
time from surge onset to ovulation ranging from 22 – 26 hours (17,18). One important 
characteristic of the LH surge in many species, including rodents (20), sheep (21), and humans 
(22), is that it is sexually dimorphic. In sheep, exogenous estrogen treatment, whether alone or 
preceded by progestin treatment, stimulates surge-like secretion of LH in ovariectomized ewes, 
but not in castrated male- or female-oriented rams (23).  
 




During the early follicular phase, there is a transient rise in FSH secretion that occurs prior to a 
nadir the day before the preovulatory LH surge. After this nadir, there is a surge in FSH secretion 
that is coincident with the surge of GnRH and LH release prior to ovulation, though of less 
magnitude than that of LH (likely due to inhibin release from the ovary, which will be discussed 
later in this chapter) (24). FSH secretion throughout the rest of the cycle is controlled by the 
negative feedback effects of both estradiol and inhibin (both derived from antral follicles). At this 
stage of the cycle, modest, transitory elevations in inhibin are thought to control the overall level 
of negative feedback. In contrast, estradiol is responsible for the day-to-day fluctuations in the 
concentration of FSH (25). Another peak and nadir in FSH follows approximately 24 and 42 hours 
after the first peak and nadir, respectively. During the luteal phase, small increases in the FSH 


















Figure 1. Schematic illustrating hormone secretory profiles across the follicular phase in the ewe. 
Circulating progesterone (blue) rapidly declines after luteolysis (1) followed by an increase in 
GnRH (green) and LH (pink) pulse frequency concomitant with a decrease in amplitude (2). Rising 
estradiol (orange) levels (3) give rise to the GnRH and LH surges (4) which trigger ovulation. 
Prog, progesterone; GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; FSH, 




4. Ovarian Development and Function 
 
The process leading up to the formation of primordial follicles takes place during early fetal life, 
occurring shortly after sexual differentiation, or approximately day 35 of gestation, in sheep (27). 
Initially, mitotically active oogonia in the cortical region of the developing ovary interact with 
adjacent mesonephric cells to form the ovigerous cords. After oogonia become isolated from the 
interstitium, they begin to recruit and eventually form tight junctions with somatic pre-granulosa 
cells from the surface epithelium. Once attached, oogonia proliferate and/or enter meiosis (28).  
Concurrent with some germ cells proliferating or initiating meiosis, there are others that are 
undergoing apoptosis (approximately 80% of germ cells). Often, germ cells in the early stages of 
meiosis are adjacent to germ cells undergoing apoptosis. The formation of primordial follicles in 
the fetal ovary begins around gestation day 75 in sheep and day 90 in cattle (28). Each primordial 
follicle consists of an oocyte surrounded by a single layer of granulosa cells (range of granulosa 
cells: 3 to 52)(29). More than 75% of these growing follicles undergo atresia by gestation day 90 
in sheep, leaving young sheep with approximately 40,000 to 300,000 primordial follicles (high 
level of individual variability). Once follicles emerge from the primordial follicle pool they are 
committed to gonadotropin-independent growth. Drastic increases in size are observed as 
primordial follicles transition to the primary stage; the oocyte enlarges due to 3- to 10-fold 
increases in the volume of the smooth endoplasmic reticulum, mitochondria, ribosomes, and lipid 
droplets, and the granulosa cells increase in number (range 30 to 520) and become cuboidal in 




Even though the follicular phase comprises only 20% of the estrous cycle, follicular growth and 
atresia occurs during the entire estrous cycle in response to fluctuations in circulating levels of 
FSH and LH. As such, antral follicles are normally always present on the ovary. However, it is 
important to recognize that the majority of “follicle life” is spent in preantral stages. Generally 
speaking, follicles can be placed into 5 main categories based on the respective stage of 
development during folliculogenesis (27): primordial, committed, gonadotropin-responsive, 
gonadotropin-dependent, and ovulatory. (1) Primordial follicles are the largest population of 
follicles present. The oocyte and granulosa cells of these follicles contain receptors for certain 
growth factors, but not for LH or FSH. After emerging from the primordial pool, follicles enter a 
process of growth and development that ends in either atresia or ovulation. (2) Committed follicles, 
or primary and small preantral follicles, are not yet sensitive to FSH and LH secretion, but do 
undergo continual growth with a low rate of atresia. Additionally, during the committed stage, the 
zona pellucida begins to develop. (3) Gonadotropin-responsive follicles (range from large 
preantral to small-medium antral in size) develop a LH-responsive theca interna and FSH-
responsive granulosal cell layer, while the phenotypic profile of the cumulus cells differentiates in 
response to oocyte-mediated signals. During this stage, there is also an increase in the number of 
follicles that undergo atresia coupled with an increased requirement for gonadotropins. (4) 
Medium-large antral gonadotropin-dependent follicles are highly susceptible to changes in 
concentrations of circulating FSH and LH. If FSH concentrations are low prior to the development 
of LH receptors in granulosa cells, these follicles will become atretic. Additionally, there is a high 
rate of atresia that is associated with the development and emergence of ovulatory follicles. (5) 
Ovulatory follicles are unique in that they can survive low levels of circulating FSH because the 
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granulosa cells express LH receptors. As the name suggests, these follicles rupture in response to 
surge-levels of LH; i.e., ovulation.  
 
Cows are single-ovulators that have 2 to 3 well-characterized FSH-induced waves of recruitment, 
selection, dominance, and atresia of antral follicles over a 21-day cycle. In contrast, ewes may 
experience many waves (ranging 2 to 6) that sometimes overlap (30), each spanning 4 to 8 days 
during a 17-day cycle (31), and often potentially produce more than one ovulatory follicle (32). A 
wave begins when small quantities of FSH are released from the anterior pituitary in response to 
a lessening of negative feedback (estradiol and inhibin) as a result of ovulation of a dominant 
follicle or atresia of potentially dominant follicles. This rise in FSH produces the growth and 
development of a cohort of small gonadotropin-dependent antral follicles that emerge from a pool 
of gonadotropin-responsive follicles (33,34). These emerging follicles grow to ovulatory size (5 
to 8 mm in the ewe, 15 to 18 mm in the cow) and develop granulosa cell-bound LH receptors, 
gaining the ability to switch dependence from FSH to LH. They also start to produce large 
quantities of estradiol and inhibin A, which in turn, act in conjunction to suppress FSH release 
from gonadotropes of the anterior pituitary gland. The deprivation of FSH release limits the growth 
of other gonadotropin-dependent follicles and eventually leads to atresia in these follicles (35). 
The remaining potentially ovulatory follicles that have achieved LH dependence may ovulate 
shortly after atresia of the previous ovulatory follicle if an LH surge occurs, or stop producing 
estradiol and become atretic within approximately 72 hours if a LH surge does not occur, thus 




Follicular rupture, or ovulation, is initiated by an increase in 3′5′-cyclic adenosine monophosphate 
(cAMP) in theca and granulosa cells that is induced by the LH surge and ultimately acts to block 
the synthesis of estradiol from progesterone. Rupture of the oocyte is accomplished by follicular 
hyperemia and proteolytic activity, coupled with contractions of smooth muscle cell-types in the 
follicular wall (37). The preovulatory rise in LH secretion also stimulates the release of urokinase-
type plasminogen activator (uPA) from the ovarian surface epithelium, which aids in the 
conversion of interstitial plasminogen to plasmin. The resulting structural degradation of the apical 
wall via activation of collagenases and collagenolysis is potentiated by increases in transcription 
of matrix metalloproteinases (MMPs) in response to TNFα release from the thecal endothelium 
(38,39). Following ovulation, the steroidogenic cells of the CL are formed by transformation of 
granulosa cells into large luteal cells and thecal cells into small luteal cells (40). Development of 
the CL is associated with angiogenesis and marked changes in cellular function. Within luteal 
tissue, large cells are thought to secrete most of the total progesterone released from the CL and 
are unresponsive to LH. One explanation for this finding is that these cells contain 6-fold more 
steroidogenic acute regulatory protein (StAR) and 2.4-fold more endozepine – two proteins critical 
for the production of progesterone – than small luteal cells (40). Alternatively, small luteal cells 
secrete progesterone via LH-mediated stimulation of StAR (41). Evidence also shows that growth 
hormone acts in conjunction with LH to provide supplemental luteotropic support in ruminants 
(42).   
 
The structural demise of the CL, which is preceded by a loss of steroidogenic function, is referred 
to as luteolysis. This structural regression is induced by the uterine-derived luteolytic factor, 
prostaglandin F2α (PGF2α), in sheep. PGF2α enters the ovarian artery from the utero-ovarian vein 
14 
 
via a countercurrent exchange mechanism that allows for local delivery of this prostaglandin (43). 
There are multiple pathways by which PGF2α may exert its effects; these major processes include 
luteal secretion of oxytocin (44), rapid reduction in luteal blood flow (45) and progesterone 
synthesis (46), and induction of apoptotic mechanisms and structural luteolysis (47). These 
processes ultimately lead to the functional (termination in progesterone synthesis) and structural 
(degradation of luteal tissue) demise of the CL.  
 




The relatively small GnRH neuron population (1,000 to 2,000 neurons) is found dispersed 
throughout the diencephalon, but predominantly existing in the POA (50%) for most mammalian 
species. The remaining neurons are scattered throughout the Diagonal Band of Broca (dBB), 
anterior hypothalamic area (AHA), and the mediobasal hypothalamus (MBH), which encompasses 
the arcuate nucleus (ARC), dorsomedial nucleus (DMH), and ventromedial nucleus (VMN) (48). 
GnRH cells are multipolar, have extensive dendritic processes, and the majority extend one or 
more fibers to the median eminence (ME). These GnRH neuronal processes extend to the external 
zone of the ME where the GnRH peptide can be released into the portal vasculature at the stalk 
median eminence that functionally connects this area to the anterior pituitary gland.  
 
As previously mentioned, GnRH neurons are devoid of both ERα and PR, signifying that the 
effects of these steroids are likely mediated through neuronal intermediates. Over the course of the 
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last half-century, a plethora of intermediates containing steroid receptors have been implicated in 
the control of GnRH release in ewes. These include classical neurotransmitters such as dopamine 
(49,50), gamma-aminobutyric acid (GABA) (51), glutamate (52), and norepinephrine (NE) 
(53,54) in A1 noradrenergic cells, more recently-discovered neuropeptides such as kisspeptin (55), 
galanin (56), orphanin-FQ (OFQ) (57), and RF-amide related peptide 3 (RFRP3) (58), and other 
known neuropeptides such as dynorphin (59), neurokinin B (NKB) (60), β-endorphin (49), 
neuropeptide Y (NPY) (50), and somatostatin (SST) (61). Within the last decade, particular interest 
has grown in a population of neurons that exist within the ARC that co-express kisspeptin, NKB, 
and dynorphin (thus given the name KNDy neurons)(62). In sheep, afferents from KNDy neurons 
project to the POA where 40% of GnRH cell bodies are found to be contacted by KNDy inputs 
(63). Additionally, 95% of ARC KNDy neurons co-express ERα (64,65) and recently, KNDy 
neurons have been shown to project to 60% of MBH GnRH neurons (66). These lines of evidence 
make KNDy neurons likely candidates in mediating estrogenic effects on GnRH neurons in sheep. 
Based on genetic mutations and functional evidence from pharmacological studies using receptor 
agonists and/or antagonists, the effects of kisspeptin (67,68) and NKB (69,70) are generally 
accepted as being stimulatory, while the effect of dynorphin (71,72) is inhibitory, to GnRH. 
Another potential candidate, which is the focus of some of the work in this dissertation, is galanin. 
This neurotransmitter is co-localized in a subpopulation of GnRH neurons and its expression is 
stimulated by estradiol (56). Galanin-immunoreactive neurons are distributed throughout the 
diencephalon, including areas of the hypothalamus – the PVN, AHA, and ARC – and have been 
shown to express ERα (73). Although galanin can act via receptors Gal-R1, Gal-R2, and Gal-R3 
(mRNA for all three is found in the POA, PVN, and ARC), only Gal-R1 protein is found in ovine 
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GnRH neurons (74,75). Neither the effects of galanin, nor its receptor agonists and antagonists, 





The discovery of kisspeptin has led to significant developments in the understanding of the neural 
mechanisms controlling reproductive function.  Kisspeptin was originally discovered as a tumor 
metastasis suppressor gene (76), but since has been shown to be a potent stimulator of GnRH 
release. Kisspeptin is part of a family of RF-amide related peptides (RFRP), a product of the Kiss1 
gene, and a ligand for a protein-coupled membrane receptor, GPR54 (now termed “Kiss1R”) (77–
79). Kisspeptin is a 54 amino acid peptide (kisspeptin/kisspeptin-54) cleaved from an initial 145 
amino acid peptide encoded by the Kiss1 gene and may undergo further proteolytic processing to 
form short kisspeptin peptides (kisspeptin-14, -13, -10) with similar binding affinities to Kiss1R 
(77,78,80). The criticality of kisspeptin-Kiss1R signaling in reproduction function was first 
discovered when two independent studies in humans reported that mutations in the Kiss1R gene 
resulted in idiopathic hypogonadotropic hypogonadism, which precluded pubertal development, 
reduced levels of gonadotropins, and caused infertility (81,82). Furthermore, genetic studies using 
mice with targeted deletion of Kiss1R or Kiss1 produced the same phenotypic abnormality of 
reproductive dysfunction (81,83,84). Thus, kisspeptin involvement in reproductive function 




In virtually all mammals studied to date, kisspeptin neurons are clustered in two distinct brain 
regions: the POA and MBH. In addition to these, a few smaller clusters of kisspeptin cells are 
found in other hypothalamic areas (85–88). In sheep, kisspeptin neurons in the POA are scattered 
medially and do not reside near the wall of the third ventricle as they do in rodents (85,88,89). In 
the MBH, kisspeptin neurons are found throughout the rostral, medial, and caudal regions of the 
ARC (85,88,89). Several lines of evidence demonstrate that kisspeptin neurons are steroid-
sensitive and are involved in the mediation of both positive- and negative- ovarian hormone 





The genes that encode NKB and NK3R – TAC3 and TACR3 – are widely expressed throughout 
the hypothalamus, including the ARC, VMN, and lateral hypothalamic area (LHA) (90,91). While 
NKB immunoreactivity in cell bodies is principally found within the ARC in sheep (60) and rats 
(92), NK3R cell and fiber immunoreactivity is found throughout the septal region, POA, and MBH 
in sheep (93), rats (94), guinea pigs (95), and humans (94). Although a large percentage of NK3R 
cells are found in close proximity to GnRH neurons in sheep, no report of colocalization has been 
published. Additionally, nearly 60% of NK3R-immunoreactive cells in the ARC are in close 
contact with NKB fiber terminals (93). Therefore, the regulation of GnRH by NKB occurs via 




Association of the tachykinin NKB with reproduction was first demonstrated in the early 1990’s 
when Naomi Rance, Ph.D. discovered that NKB mRNA expression was significantly increased in 
the infundibular nucleus (analogous to the ARC in other species) of postmenopausal women (91). 
Little further work was done on this neuropeptide until 2009, when patients with mutations in 
TAC3 or TACR3 who presented with hypogonadotropic hypogonadism and infertility (96) similar 
to the above mentioned phenotypic dysfunction presented in patients with mutations in Kiss1 gene 
or Kiss1R (81,82), were first reported.  Along with NKB, other tachykinins such as substance P 
(SP) and neurokinin A (NKA) act through three known tachykinin receptors: neurokinin 1 receptor 
(NK1R), neurokinin 2 receptor (NK2R), and NK3R. All three receptor subtypes are 7 membrane 
domain receptors that activate the phosphatidylinositol transduction pathway. While these 
receptors are not exclusively specific for any tachykinin (substance P, neurokinin A, or NKB), 
each receptor has higher affinities for one tachykinin: NK1R preferentially binds to substance P, 




Over the last decade, galanin (29 amino acid sequence) has been implicated in the control of GnRH 
release (43,98). This neuropeptide is widely expressed throughout the central and peripheral 
nervous systems (56), with the highest concentrations observed in the MBH in numerous species, 
including rats (99), primates (100), pigs (101), and sheep (102). Galanin has been implicated to 
play a role in a wide range of neuroendocrine functions. Aside from reproduction, 
intracerebroventricular or intravenous administration of galanin in rodents (103) and women (104), 
respectively, stimulates prolactin and growth hormone release. Similarly, intracerebroventricular 
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injections of galanin in sheep results in dose-dependent increases in plasma growth hormone 
concentrations (105).  
 
In the POA, galanin is colocalized with a sub-population of GnRH neurons in female rats 
(approximately 65% of GnRH neurons) (106,107) and female primates (approximately 10% of 
GnRH neurons) (108). In rodents, this percentage is found to be sexual dimorphic; in males, 
approximately 20% of POA GnRH neurons contain galanin immunoreactivity, compared to the 
previously stated 65% of GnRH neurons in females (109). This population is also highly sensitive 
to steroid environment. During proestrus, significantly higher levels of galanin are found in the 
POA compared to during estrus (109). Moreover, the incidence of colocalization of GnRH and 
galanin peptide at the level of single axon terminals in the median eminence was dramatically 
decreased by ovariectomy (approximately 23% colocalization), but this was reversed after 
administration of estradiol (approximately 55% colocalization). The incidence of vesicular 
colocalization was also greater in females (45%) compared to males (3%) (110).  Furthermore, 
galanin receptor subtype 1 (Gal-R1) has been observed in GnRH neurons in the POA of rats (111) 
and the presence of galanin close-appositions on GnRH neurons has been shown in rats (109), 
mice (112), and humans (113). 
 
Galanin is released in pulses into the hypothalamus-pituitary vasculature, with much higher 
concentrations found in the portal blood supply than in the peripheral circulation in rodents (7-fold 
difference); the majority of these pulses are coincident with pulses of GnRH (114). Moreover, it 
has been demonstrated through triple-label immunocytochemical staining that a subpopulation of 
GnRH neurons coexpressing galanin in the POA is activated during the LH surge (as indicated by 
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the presence of nuclear c-Fos) in female rats (115). Additionally, administration of galanin to 
ovariectomized animals has no significant effect on LH secretion. However, after implantation of 
progesterone and estrogen, stimulation of LH release was observed (116).  
 
In sheep, the amount of colocalization between GnRH and galanin does not appear to be altered 
by steroids (117), however, the number of galanin fiber close-appositions to GnRH cell bodies was 
increased in the presence of estradiol (56). Furthermore, the number of galanin-immunoreactive 
neurons in a subpopulation in the caudal part of the POA was increased after administration of 
estradiol compared to controls; a report that was consistent with the discovery of ERα expression 
in galanin neurons (73). Galanin receptor subtypes 1 to 3 (Gal-R1, Gal-R2, Gal-R3) have also been 
detected throughout the POA, hypothalamus, and pituitary gland (74), and a subset of GnRH 
neurons have been shown to express Gal-R1 mRNA (similar to what is seen in female rats) (75). 
Although Gal-R2 has been observed in a large number of neurons throughout the hypothalamus, 
it has not been shown to colocalize with GnRH in sheep (118).  
 
 
The GnRH Pulse generator  
 
The current model for GnRH pulse generation centers on KNDy neuronal activity within the ARC 
nucleus. Several neuroanatomical characteristics of KNDy neurons led to the hypothesis that these 
neurons play an important role in driving episodic GnRH release: 1) KNDy neurons contain two 
stimulatory peptides, kisspeptin and NKB, and one inhibitory peptide, dynorphin, as well as ERα; 
2) They express receptors for NKB, neurokinin 3 receptor (NK3R) (93), and dynorphin, κ-opioid 
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receptor (KOR) (119), suggesting extensive reciprocity and allowing for autocrine and paracrine 
actions within this interconnected population of cells; 3) Afferents from KNDy neurons extend to 
the POA where they contact 40% of GnRH cell bodies, and to the MBH where they project to 60% 
of MBH GnRH neurons; and 4) KNDy neurons form a vast interconnected network (120). Due to 
the observation that GnRH neurons contain receptors for kisspeptin (GPR54 or kiss1r) (121), but 
not receptors for NKB (NK3R), it was proposed that kisspeptin, but not NKB, output from KNDy 
neurons is responsible for stimulating pulsatile GnRH release (Fig. 1.2.). Thus, within the KNDy 
network, NKB and dynorphin act in tandem to initiate (NKB) and terminate (dynorphin) release 
during each GnRH pulse (122). During pulse onset, the initial release of NKB stimulates KNDy 
neuron activity in an autocrine and paracrine manner. Kisspeptin is secreted from KNDy neurons, 
which acts to stimulate GnRH neurons, resulting in a subsequent GnRH pulse. Within a few 
minutes, dynorphin release inhibits KNDy neuron activity, and after approximately 5 minutes, 
kisspeptin release ceases and the GnRH pulse is terminated. Although these observations make 
KNDy neurons strong candidates for driving pulsatile GnRH release, the possibility still exists that 
other neurotransmitters or neuropeptides may contribute to steroidal regulation of pulsatile GnRH 













Figure 1.2. Model of synchronous activity among KNDy cells to regulate GnRH pulse frequency. 
Pulse onset begins with NKB (purple) acting via NK3R within the KNDy network (purple dashed 
line) to stimulate the release of kisspeptin (green). Kisspeptin acts via KISS1R to stimulate the 
release of GnRH (blue) and activate surrounding unidentified neurons that contain KISS1R (gray). 
Pulse termination begins with dynorphin (red) release from KNDy neurons that acts via KOR to 
inhibit activity in KNDy neurons and/or GnRH neurons and/or the unidentified KISS1R-
containing neurons. Rdyn, kappa-opioid receptor; RKs, KISS1R; RNKB, NK3R. From Nestor et al. 




KNDy Neurons and Steroid Feedback 
 
Several studies have produced evidence that implicate individual KNDy neuron components (i.e., 
kisspeptin, NKB, or dynorphin) as mediators of ovarian steroid feedback. Recent work has 
established a role for kisspeptin ARC neurons in mediating the negative feedback effects of 
estrogen (123). In situ hybridization studies have demonstrated that removal of endogenous 
estradiol release by OVX increases, and estradiol administration decreases, the number of Kiss1-
expressing neurons in the ARC of many species (88,123,124). The negative feedback effects of 
estradiol on ARC kisspeptin neurons are controlled via ERα (125), acting through a non-classical 
mechanism that does not involve estrogen response element (ERE) signaling (126). Increases in 
Kiss1 mRNA have been observed after OVX in primates (127), sheep (128), and rats (129), while, 
decreases in Kiss1 mRNA have been observed after estradiol treatment in sheep (130). 
Furthermore changes in ARC Kiss1 mRNA displayed a strong positive correlation with changes 
in LH pulse amplitude in sheep (130). These findings provide evidence that estradiol acts to inhibit 
GnRH/LH pulse amplitude by suppressing kisspeptin release from KNDy neurons.  
In contrast to estradiol, kisspeptin does not appear to mediate progesterone negative feedback. 
Rather, several reports have provided evidence for dynorphin in this role. As previously 
mentioned, GnRH/LH pulse frequency is reduced by progesterone. This negative feedback is 
generally accepted to occur through the inhibitory actions of endogenous opioids (13,43,131) such 
as dynorphin. Data that support this hypothesis include the findings that nearly all KNDy neurons 
contain PR (59), administration of a KOR antagonist into the MBH increases LH pulse frequency 
in luteal phase ewes (71),  OVX decreases ARC prepro-dynorphin mRNA (132), and 
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administration of RU486 (PR antagonist) into the ARC disrupts progesterone negative feedback 
(130). These findings provide evidence that progesterone acts to effect GnRH/LH pulse frequency 
by acting through dynorphin.  
 
 
The GnRH/LH Surge  
 
The rise in estradiol during late follicular phase is now generally accepted as the ovarian signal 
that induces GnRH and LH surges. The mechanism by which estradiol simulates GnRH release is 
still poorly understood, but some important aspects have been defined based on early discoveries. 
The first is that local administration of estradiol-containing implants into the VMN-ARC region, 
but not other locations within the hypothalamus, induces surge secretion of GnRH and LH in sheep 
(133). The second is that there is no neuroanatomically-distinct population of GnRH cells 
identified to date that participates during the surge; c-Fos expression is found in approximately 
40% of GnRH cells regardless of location (including the POA and MBH) during an estrogen-
induced surge (134). Finally, knife cuts through the rostral hypothalamus (i.e. deafferentation of 
MBH GnRH neurons) either block or greatly reduce an estrogen-induced surge (135). These 
observations provide a foundation for the hypothesis that estradiol acts in the MBH to evoke a 
signal that eventually ends with a massive release of GnRH.   
 
The surge induction process has been hypothesized to occur in three stages (136). The first stage 
is activation, described as a period lasting between 4 and 14 hours during which estradiol must be 
present and acts as the “activating” agent of the surge induction process. The second stage, called 
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transmission, is defined as the 6 to 8 hour period after the activation stage that does not require the 
presence of estradiol (after activation, and once this process has started, signaling within the 
hypothalamus becomes independent of estradiol) (43). The third stage is the called the secretory 
phase. During this period, GnRH secretion has been initiated and is likewise estradiol-independent.  
 
Many neurotransmitters have been implicated in the induction of the GnRH surge. Systems with 
largely correlative data supporting a role in controlling GnRH surge release include dopaminergic 
and somatostatinergic activity within the VMN and galaninergic activity in the POA and ARC. 
Levels of the dopamine metabolite 3,4-dihydroxyphenylacetic acid significantly increase in the 
VMN coincident with the LH surge in estrogen-treated ovariectomized ewes, with levels 
remaining elevated 10 – 20 hours post-estrogen stimulus. Moreover, inhibition of catecholamine 
(dopamine and NE) synthesis in the VMH delays the onset and time to peak of the LH surge, as 
well as attenuates the overall response (137). Somatostatin neurons in the VMN contain ERα (61) 
and acute estradiol treatment increases levels of prepro-somatostatin mRNA by approximately 
50% in the VMN (138). Additionally, c-Fos expression is increased in somatostatin neurons during 
the naturally occurring LH surge and after an estrogen-stimulus during anestrus in ewes (139). 
More recently, however, administration of a somatostatin receptor agonist, octreotide, or an 
antagonist, CYN154806, into the third ventricle during an estrogen-induced surge had no effect 
on the timing or magnitude of the LH surge in ewes (140). Depending on the stage of cycle, galanin 
(and its receptors) is differentially expressed in numerous areas in sheep, demonstrating that this 
neuropeptide is highly influenced by steroids (56). Galanin-immunoreactive cell numbers in the 
POA are elevated in the presence of surge-inducing levels of estradiol and more than 50% of these 
neurons contain ERα in ewes (73). Moreover, galanin mRNA expression in the POA is highest 
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during mid-follicular phase at the start of the GnRH surge (56).  Collectively, these data lead to 
the proposition that this neuropeptide could participate in the surge induction process during the 
activation and/or secretory phase. 
 
Other neurotransmitters/neuropeptides that have also received significant attention are β-
endorphin, NE, kisspeptin, and NKB. As previously discussed, endogenous opioid peptides (EOP), 
such as β-endorphin, are inhibitory to GnRH release. Because of this, the hypothesis was 
developed that withdrawal of an EOP inhibitory signal may be permissive to the onset of GnRH 
release. Evidence for this is found in the observations that levels of β-endorphin expression 
decrease during surge activation (141), concentrations of β-endorphin in the ME increase during 
the transmission phase (142), and then decrease during the secretory phase when the GnRH surge 
occurs (143). Additionally, administration of the opioid receptor agonist morphine or DAMGO 
([D-Ala2, N-MePhe4, Gly-ol]-enkephalin), another mu EOP receptor agonist, to adult ewes, 
delayed, but did not block, the onset of estrus and the GnRH surge (144,145). Taken together, 
these pharmacological data indicate that EOP withdrawal is necessary, but not sufficient, for the 
LH surge. However, administration of the EOP receptor antagonist, naloxone, had no effect on the 
GnRH surge (144). Early evidence for noradrenergic involvement in the GnRH surge is found in 
the observations that track tracer injections in the DBB/rPOA of the sheep brain resulted in 
retrograde labelling of cells with FlouroGold that colocalized with estrogen receptor in the rostral 
and medial regions of the A1 field of the brain stem (146). Additionally, A1 noradrenergic cells in 
the brain stem were acutely stimulated by estrogen injected in OVX ewes (147). Furthermore,  NE 
release in the POA during the transmission phase (148) and ME during the secretory phase (149) 
is increased, and blockade of A1-noradrenergic action reduces the magnitude of the LH 
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surge (150). These findings substantiate the notion that noradrenergic cells found in this region of 
the brain stem may be involved in estrogen positive feedback.  
 
Recent published reports have postulated that kisspeptin contributes to, but is not fully responsible 
for, activation of the GnRH surge. Similarly to what is shown with blockade of A1-noradrenergic 
action, kisspeptin antagonist infusion reduces the magnitude of the LH surge by approximately 
50% in ewes during an estrogen-induced LH surge (151). Moreover, estrogen treatment stimulates 
kisspeptin expression in the population of kisspeptin cells found in the POA (152), which is similar 
to what is reported in the AVPV of rodents (153), and raises the possibility that POA kisspeptin 
neurons in sheep participate in the estrogen-induced preovulatory LH surge (152). Importantly, as 
previously mentioned, estrogen acts in the MBH, not the POA, to initiate the LH surge in sheep 
(133). As such, there is supporting evidence that POA kisspeptin cells are indirectly activated by 
estrogen positive feedback. Immunohistochemical studies have shown that levels of Kiss1 mRNA 
and kisspeptin/c-Fos colocalization in the caudal ARC (KNDy neurons) are significantly elevated 
1 hour post-estrogen stimulus (15 to 19 hours before the resulting LH surge) in OVX ewes, and 
tend to increase during the late-follicular phase (1 to 2 hours before the resulting LH surge) in 
intact ewes (154). During the LH surge, increased levels of c-Fos expression are found in POA 
kisspeptin and GnRH neurons in intact cycling ewes (89,155). Thus, there is supporting evidence 
that kisspeptin neurons in the POA act during the secretory phase of the GnRH surge induction 





As discussed previously, negative feedback effects of estrogen are likely mediated through 
kisspeptin. Briefly, in the ARC, neuronal expression of kisspeptin increases after OVX, but cell 
numbers return to normal after estradiol-containing implants in OVX ewes (88,156). During the 
late follicular phase, kisspeptin gene expression and protein content in the middle and caudal ARC 
increases (121) and, during an estrogen-induced surge, show increased levels of c-Fos (89,157). 
The mechanisms whereby kisspeptin may be involved in both negative and positive estradiol 
feedback remains to be determined. The most feasible explanation is that positive feedback events 
result from transient activation of kisspeptin cells, while negative feedback events result from 
continuous inhibition of kisspeptin cells (158). Thus, as reported by Smith et al. (154), large, acute 
increases in estradiol, such as during the LH surge, result in the activation of kisspeptin neurons 
in the ARC. In contrast, constant, low levels of estradiol result in the inhibition of kisspeptin 
expression in the ARC (121).  In the AVPV in rodents and POA in sheep, administration of 
estradiol increases the expression of Kiss1 mRNA (156,159), thus providing evidence for a 
similarity in the currently-held hypotheses of the activity of kisspeptin neurons in the POA (AVPV 
region) of rodents and sheep.  
 
Numerous lines of evidence implicate another KNDy peptide, NKB, in the stimulation of the 
GnRH and LH surge in ewes. Microimplantation of senktide, a NK3R agonist, into the ovine 
retrochiasmatic area (RCh) elicits surge-like increases in LH (69,70). Conversely, pharmacologic 
blockade of NK3R signaling within the ovine RCh reduces the amplitude of the LH surge by 
approximately 50% (70). These findings demonstrate that NK3R activation in the RCh is essential 
for full expression of the preovulatory LH surge. To further support this hypothesis, NK3-SAP 
injection dramatically decreased the numbers of NK3R-containing neurons in the RCh and reduced 
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the amplitude of an estrogen-induced LH surge by approximately 50% (Goodman et al., 2018, 
International Congress of Neuroendocrinology Abstract). NK3-SAP is a conjugate of saporin, a 
ribosome-inactivating toxin, and [MePhe7]-NKB, a potent and selective NK3R agonist, used to 
selectively ablate NK3R neurons. Further, microimplantation of senktide into the ovine RCh 
induces an increase in c-Fos expression in kisspeptin neurons of  the ARC and infusion of a Kiss1R 
antagonist, Kp-271, completely blocks the surge-like increase in LH induced by RCh senktide 
administration (160). Neurons in the RCh project directly to KNDy neurons (160),  and as such, 
there is supporting evidence that NK3R neurons in the RCh (the phenotype of which remain 
unknown) innervate KNDy neurons in the ARC and provide a circuit by which NKB acts in the 
RCh to stimulate kisspeptin release, culminating in a GnRH surge during the secretory phase of 
the induction process.  
 
To summarize, multiple neural systems are suggested to participate in the estrogen-induced LH 
surge in the ewe: during the activation phase, estradiol acts in the ARC to stimulate kisspeptin 
release from KNDy neurons, and potentially in the brainstem to stimulate NE release. During the 
transmission phase, increases in stimulatory input from NE and kisspeptin to GnRH neurons is 
limited by increases in inhibitory inputs from β-endorphin. As the inhibitory signal from β-
endorphin wanes, NK3R-containing neurons in the RCh are activated by NKB and stimulate the 
kisspeptin release from KNDy neurons that drives GnRH secretion during the surge. During the 
secretory phase, additional stimulation is supplied by the population of kisspeptin cells in the POA 
that are innervated by ARC KNDy neurons. Other potential supplementary input is provided by 
noradrenergic efferent neurons in the A1 region of the brainstem (149). Activity involving the 
population of NK3R-containing cells in the RCh are the focus of work discussed in this dissertation 
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and are depicted in Figure 1.3. Specifically, NK3R activation within the RCh is necessary for 
expression of the LH surge and these cells act to increase GnRH/LH secretion during a surge by 














Fig 1.3. Schematic representation of connectivity between neurons implicated in the 
luteinizing hormone surge in sheep 
 
Figure 1.3. NK3R-containing neurons (grey) in the RCh project to KNDy neurons in the ARC.  
KNDy neurons coexpress kisspeptin (green), NKB (purple) and dynorphin (Dyn) (red), and 
innervate kisspeptin (green) and GnRH neurons (blue) in the POA. The source of NKB that 
activates NK3R-containing neurons in the RCh is currently unknown. ac, anterior commissure; 








6. Mechanisms for Sexual Differentiation of Reproductive Function  
 
The development of sexual differentiation of reproductive function has been thoroughly 
investigated by examining both prenatal organization and activation of postnatal effects of gonadal 
steroids. Early mammalian development is characterized by a series of “critical periods” during 
which the brain is sensitive to the effects of steroids that cause sex differences in behavior and 
neuroendocrine development during adulthood. Permanent, organizational changes in neural and 
neuroendocrine systems that occur during gestation are referred to as prenatal organization and 
many occur in response to steroid influences. In comparison, postnatal activation is described as 
transient, activational changes that result from exposure to these steroids during adulthood and are 
reversible (161). Normal sexual differentiation of the brain is regulated by testicular testosterone 
secretion during the prenatal period in humans, non-human primates, sheep, and guinea pigs, but 
is not completed until the neonatal period in rodents (162). At birth, without the intervention of 
testosterone, the resultant offspring will display a female-typical phenotype by default. However, 
under the direction of the SRY gene (sex-determining region Y) on the Y chromosome, the gonads 
will differentiate into testes and the subsequent production and secretion of testosterone and anti-
Mullerian hormone (AMH) results in the regression of the female reproductive tract and 
development of the male reproductive tract, leading to a male-typical phenotype. In addition, 
neuroanatomical changes in neural and neuroendocrine systems underlie the masculinization of 
sexual behavior and defeminization of the estrogen-induced GnRH/LH surge (163), defining 




A number of animal models have been established to investigate how steroids alter postnatal 
reproductive neuroendocrine function. These studies have taken the form of examining the effect 
of exposing females to exogenous testosterone (or other androgens such as dihydrotestosterone 
(DHT)) during development and/or removing/blocking endogenous testosterone in males during 
development and then investigating the neural pathways by which these specific effects are 
mediated. As mentioned above, within these critical periods exists windows in which specific traits 
may be susceptible to exposure to steroids. In rodents and other species with short gestation 
periods, the majority of these developmental periods occur postnatally, with sexual differentiation 
of the brain arising only a few days after birth (164). Early studies demonstrated that increases in 
androgens are detectable in rats at day 15.5 of gestation and peak at day 18 of gestation and 
immediately after birth (165,166). This “masculinization programming window” is essential for 
differentiation of sexual behavior and neuroendocrine function in these animals (163,165,166), 
and also normal male phenotype, such as differentiation of the internal reproductive tract 
(epididymis, vas deferens, seminal vesicles, and prostate) and external genitalia (penis, scrotum, 
and perineum) (167). In comparison, sheep, and other species with long gestation periods (i.e., 
non-human primates and guinea-pigs), experience these critical periods prenatally (164). Exposure 
of female sheep fetuses to levels of testosterone (weekly; 200 mg testosterone cypionate) similar 
to that observed in males while in utero (between days 30 and 86 of a 147-day gestation), results 
in formation of male genitalia and development of the male reproductive tract (161). Comparably, 
in male guinea pigs, increases in testicular androgen levels occur between days 28 to 36 of 
gestation and correspond to a critical window responsible for sexual differentiation of the brain 




The question still exists whether exposure to androgen or estrogen while in utero is responsible 
for male patterns of GnRH release, and whether the absence of these steroids is responsible for 
female pattern of GnRH release. Several experiments in sheep over the last few decades have 
demonstrated the importance of exposing fetal brains to the correct steroid environment and the 
reproductive outcomes after birth if they are exposed to the incorrect steroid environment. 
Particularly, the impact of in utero androgen exposure on steroid negative feedback can be seen in 
studies examining sex differences in the pubertal decrease in sensitivity to steroid feedback 
inhibition on tonic GnRH release. Normal gonad-intact females – or agonadal females treated with 
estrogen implants – are highly sensitive to small amounts of estrogen prior to puberty, which 
results in low concentrations of GnRH and basal concentrations of circulating LH until the age of 
first ovulation (around 30 weeks of age) (161,169,170). In contrast, normal gonadal and steroid-
clamped agonadal males exhibit increases in tonic LH secretion much earlier (around 7 to 8 weeks 
of age), leading to the conclusion that the inhibitory brake applied prepubertally to GnRH release 
is removed much earlier in males compared to females (Fig. 1.4). Numerous studies have 
employed in utero steroid exposure techniques, as discussed above, to examine the influence of 
prenatal androgen exposure on the age of which the pubertal decrease in sensitivity to steroid 
feedback inhibition of tonic GnRH release occurs. Testosterone administered weekly to pregnant 
females from days 30 to 90 of gestation resulted in female offspring exhibiting early pubertal 
increases in GnRH and LH release that were similar to what is observed in normal males (171). 
Furthermore, depending on the dose of testosterone, the occurrence of the pubertal increase in LH 
release differed. A dose of 200 mg of testosterone resulted in a pubertal increase in LH around 10 
weeks of age, 80 mg resulted in advancement to 16 weeks, and 30 mg resulted in no advancement 
(Fig. 1.5) (172). There also seems to be a great deal of plasticity in the “critical period.” 
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Administration of 200 mg of testosterone to pregnant females treated from day 30 to 51 (early) or 
65 to 86 (late) days of gestation resulted in female offspring that presented with external genitalia 
that differed at birth (early, masculinized; late, normal), but advanced the increase in pubertal LH 
secretion to the same age: LH secretion increased at 19.3 ± 1.2 (early) and 20.4 ± 0.8 (late) weeks 
(173). Furthermore, administration of dihydrotestosterone (DHT), a potent, non-aromatizable 
androgen, to pregnant females resulted in pubertal LH increases that were similar to what is 
observed in normal males or testosterone-treated females, suggesting that this was androgen-
dependent and not due to conversion of testosterone to estrogen by aromatase.  Co-treatment of 
testosterone or DHT treated females with flutamide, an androgen receptor antagonist, reversed the 
reduced sensitivity to estrogen negative feedback normally observed in these animals (174). These 
findings lead to the conclusion that the duration of the brake applied to GnRH release prior to 













Figure 1.4. Timing of puberty in spring-born male and female lambs, and corresponding 

























Figure 1.4. Timing of puberty in spring-born male and female lambs, and corresponding changes 
in LH secretion. (A) Indices of puberty onset in gonad-intact males (sperm production) and females 
(ovulation). (B) Circulating LH concentrations from gonadectomized estradiol-treated male (dark 
green) and female (light green) lambs. (C) GnRH and LH concentrations in response to a surge-
inducing dose of estradiol (time zero) from a representative female lamb (left) and male lamb 




A major sex difference that exists between males and females is the occurrence of the LH surge 
with males unable to respond to positive feedback actions to estrogen. Similar to what has been 
discussed above with tonic GnRH and LH release, the question remains whether the prenatal 
actions of steroids play a critical role in controlling differentiation of the surge mode of GnRH 
secretion. The LH surge is inoperable in male sheep due to failure to generate adequate and 
sustained levels of GnRH release (21). After administration of surge-inducing levels of estrogen 
to normal females, a surge in GnRH and subsequent LH release clearly occurs; this phenomenon 
is not observed in males or females exposed prenatally to testosterone (21). Within the “critical 
period,” there seems to be great plasticity in terms of controlling the development of the surge 
system (depicted in Fig. 1.5). Short periods of testosterone treatment (3 weeks) beginning on day 
30 (early) or 65 (late) resulted in female offspring that could mount delayed LH surges after acute 
estradiol stimulation: the surge of LH peaked at 29.8 ± 1.6 (early) and 31.8 ± 1.3 (late) hours post-
estrogen, relative to normal time-to-peak, which is approximately 24 hours (173). Interestingly, 
administration of DHT to pregnant females (days 30 to 90 of gestation) resulted in female offspring 
that were able to produce LH surges, despite masculinization of tonic GnRH secretion, leading to 
the conclusion that the estrogenic actions of testosterone (testosterone is aromatized to estrogen) 
may be responsible for defeminization of the surge mechanism in males (175). At the time, these 
differential findings led to the conclusion that development of the neural circuitry for the tonic and 
surge modes of GnRH secretion occur independently from one another.  However, more recently, 
dual organizational effects of these steroids have been postulated to exist during development. 
Administration of testosterone to pregnant ewes between days 30 to 90 of gestation and daily 
treatment with the androgen antagonist flutamide (this will block androgenic programming of 
testosterone) starting at 8 weeks of age resulted in female offspring that exhibited partial reduction 
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of the LH surge amplitude in response to acute estradiol stimulation. Therefore, the timing of the 
surge may be programmed by estrogenic pathways, while the magnitude of the surge may be 






















Figure 1.5. Effects of androgen treatment in utero on external genitalia, neuroendocrine 
sexual maturation, and the LH surge in female lambs. 
 
 
Figure 1.5. Effects of androgen treatment in utero on external genitalia, neuroendocrine sexual 
maturation, and the LH surge in female lambs. Column 1: schematic of type of androgen treatment. 
Column 2: schematic sagittal section through the hind-quarters of representative male, female and 
androgenized female lambs illustrating the position of the penis, scrotum or vulva. Column 3: LH 
concentrations in gonadectomized estradiol-treated lambs from samples collected twice per week. 
Column 4: LH response to follicular phase concentrations of estradiol over 60 hours. (A – C) 
Androgenization occurred during the entire critical period (171). (A) Normal male lamb. (B) 
Female lamb treated with high dose testosterone from day 30 to day 86 of gestation. (C) Normal 




Prenatal exposure to steroids produces differing reproductive outcomes in adulthood. Early studies 
in females of the Dorsett breed demonstrated that exposure to testosterone from 30 to 90 days 
during gestation resulted in a period of reproductive cyclicity followed by a progressive decline in 
reproductive cyclicity that eventually led to anovulation during adulthood (177). Other breeds 
including Suffolk ewes, demonstrate similar responses (178,179). Moreover, testosterone 
exposure during different windows of the “critical period” leads to differing chronic, sustained 
effects. Most females treated with testosterone between days 60 to 90 of gestation cycled normally 
during the first and second breeding season, where those treated between days 30 to 90 became 
anovulatory during the second breeding season (177). This observation led to the conclusion that 
the steroid environment during the critical period not only affects the establishment of 
neuroendocrine feedback systems, but may also alter ovarian development which starts 
approximately on day 30 in ewes. Furthermore, the timing of neuroendocrine puberty onset in 
androgenized agonadal, estrogen-implanted females differs from that of androgenized gonadal 
females (177). Prenatal testosterone administration from days 60 to 90 resulted in a timing of 
puberty in ovary intact females that occurred at 31.8 ± 0.6 weeks, compared to 21.7 ± 1.9 weeks 
in agonadal estrogen-implanted females. Prenatal testosterone administration from days 30 to 90 
resulted in a timing of puberty in ovary intact females that occurred at 30.6 ± 1.3 weeks, compared 
to 12.4 ± 0.9 weeks in agonadal estrogen-implanted females (177). In these instances, two 
predominant questions persist: 1) why do reproductive cycles occur in lambs during the first and 
second breeding season after prenatal exposure to androgens?, and 2) what discrepancies exist that 
allow for differences in observations between the gonadectomized and ovary-intact, prenatal 
testosterone-treated females? In both cases, these outcomes are unexpected, given the observations 
from the well-studied experimental model for postnatal estrogen implantation and the resultant 
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suppressive effects on GnRH release. To address the first question, intact prenatally androgenized 
females are most likely capable of generating subtle ovulatory LH signals that may persist for one 
or two breeding seasons, as evidenced by progestogenic cycles and the appearance of ovarian 
corpora lutea (177). In the case of gonadal versus agonadal (OVX + estrogen) prenatal 
androgenized females, the pattern of release for estrogen seems to be a likely explanation. 
Administration of constant, relatively high levels of estrogen by implants, compared to 
endogenously fluctuating low levels of estrogen, after birth may result in further disruption of the 
neural circuitry controlling the GnRH surge and tonic systems, rendering surge generation 
inoperable and reproductive cycles disrupted in androgenized estrogen-implanted females 
(180,181). Furthermore, there is evidence that chronic estrogen exposure can disrupt steroid-
induced LH surges in rodents (182) and cows (183), in part by inactivating GnRH neurons (182). 
These findings lead to the conclusion that endogenous postnatal estrogen release is required to 
complete sexual differentiation, particularly at the level of the GnRH surge system.  
 
At a neuroanatomical level, the basis for sexual differentiation of the control of GnRH secretion 
remains to be fully elucidated. GnRH neurons are not sexually dimorphic with respect to number, 
distribution, or gross morphology. Therefore, sexual dimorphism most likely exists in factors 
located upstream of GnRH neurons that reside locally or from within other areas of the brain. Early 
studies demonstrated that in female lambs, GnRH perikarya receive twice the number of synaptic 
contacts than those found in male lambs of the same age: 3.6 ± 0.7 versus 1.6 ± 0.3 synapses/100 
micron of plasma membrane. Furthermore, the number of synapses on GnRH neurons from 
androgenized female lambs was similar to what was observed in males, 1.5 ± 0.5 synapses/100 
micron plasma membrane (184). Organizational effects of gonadal steroids clearly influence sex 
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differences in synaptic input to GnRH neurons; the phenotype of these contacts, however, still 
remains unclear. KNDy neurons located in the ARC are highly sensitive to steroids, which makes 
this population of cells a likely target of the organizational effects of steroids. In the ARC, twice 
the number of NKB cells are observed in adult female sheep compared to males or androgenized 
females (60,185). Moreover, a greater number of kisspeptin, dynorphin, and PR-positive cells are 
found in adult females compared to adult male sheep (185,186). Interestingly, kisspeptin cell 
numbers in the ARC have not been shown to be affected by testosterone treatment in utero because 
androgenized females do not show reduced numbers compared to normal females (186). NK3R-
positive cells in the ARC are also reduced in androgenized females compared to normal females. 
This decrease was postulated to be primarily due to changes within the above-mentioned KNDy 
cell population, as single-labeled NK3R cells did not differ between the two groups (187). These 
findings add an additional layer of sexual dimorphism, as there is clear evidence that the 
organizational effects of steroids result in a combined reduction of both ligand and receptor 
components of KNDy/NK3R signaling. This potentially contributes further to the inability of 
males to generate a GnRH surge.  
 
7. Objectives  
 
The neuropeptides NKB and kisspeptin are critical for fertility in humans and potent stimulators 
of GnRH and LH secretion in primates and sheep. Administration of a selective NK3R agonist 
within the RCh results in surge-like release of LH and increased cellular expression of Fos in 
kisspeptin neurons in the ARC of female sheep. Based on these findings, we concluded that NKB-
responsive neurons in the RCh act to stimulate GnRH secretion by inducing kisspeptin release 
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from neurons in the ARC. Furthermore, the true phenotype of NK3R-containing neurons in the 
RCh has yet to be elucidated. However, one potential neurotransmitter co-expressed in these 
neurons is galanin. The LH surge, in many species, is sexually dimorphic, occurring in females 
but not in males. Thus, investigating differences between sexes in specific brain regions provides 
an approach to test areas implicated in the control GnRH/LH surge secretion. Given this, I pursued 
the following objectives: 
 
1. To determine if sexual dimorphism in the response to NK3R activation exists within the 
RCh. Using young males and females exposed to artificial follicular phases, we examined 
if there were differences in LH secretion following senktide microimplant placement 
within the RCh on LH secretion.  
 
2. To determine whether there are fewer NKB‐containing terminals within the RCh of males 
than in females, we characterized the expression of NKB and NK3R in the RCh of male 
and female lambs collected during surge induction.  
 
3. To determine if sexual dimorphism exists for NK3R, NKB, or kisspeptin expression in the 
RCh and ARC, we assessed immunopositive cell numbers in tissue collected from acutely 
gonadectomized male and female lambs during surge induction.  
 
4. To determine whether galanin stimulates LH secretion in ewes, we injected galanin icv to 
anestrous and luteal phase female sheep. Furthermore, we characterized the expression of 




5. To determine whether galanin participates in the LH surge of female sheep, ewes were 
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Neurokinin B (NKB) is critical for fertility in humans and stimulates GnRH/LH secretion in 
several species, including sheep. We have proposed that NKB actions in the retrochiasmatic area 
(RCh) contribute to the induction of the preovulatory LH surge in sheep.  In this study, we tested 
if the response to local administration of senktide, an agonist to the NKB receptor (NK3R), is 
sexually dimorphic and examined sex differences in NKB and NK3R expression in sheep. To 
normalize endogenous hormone concentrations, all animals were gonadectomized and given 
implants to mimic the pattern of ovarian steroids seen in the estrous cycle.  In females, senktide 
microimplants in the RCh produced a significant increase in LH concentrations that lasted for at 
least 8 hrs after the start of treatment, while a much shorter increment (~2 hrs) was seen in males. 
For neuroanatomical experiments, we collected tissue from gonadectomized lambs 18 hrs after 
insertion of estradiol implants that produce an LH surge in female, but not male, sheep for 
immunohistochemical analysis of NKB and NK3R expression. As expected, there were more 
NKB-containing neurons in the arcuate nucleus of females than males. Interestingly, there was a 
similar sexual dimorphism in NK3R-containing neurons in the RCh, NKB-containing close 
contacts onto these RCh NK3R neurons, and overall NKB-positive fibers in this region. These data 
demonstrate that there are both functional and morphological sex differences in NKB-NK3R 
signaling in the RCh and raise the possibility that this dimorphism contributes to the sex-dependent 








The neuroendocrine pathways that control ovulation in females have been the subject of intense 
investigation over the last fifty years (1–5). High levels of estradiol produced by the maturing 
follicle(s) act to induce a GnRH surge that in turn elicits a corresponding surge of LH, which then 
causes ovulation. However, the molecular and neural mechanisms that mediate the interplay 
between estrogen and GnRH are still not fully understood. Intermediary neurons must participate 
in this process since GnRH neurons are devoid of estrogen receptor alpha (ERα) (6), the receptor 
subtype whereby estrogen exerts its effects.  
 
Kisspeptin signaling was shown to be critical for fertility in humans (7,8) and mice (8) and the role 
of kisspeptin in controlling GnRH secretion has been extensively examined. Importantly, 
kisspeptin neurons express ERα in numerous species (9), including sheep (10), supporting the 
likelihood of a direct effect of estrogen on these neurons. Recently, a population of kisspeptin 
neurons in the rostral periventricular area of the third ventricle have been demonstrated to mediate 
the surge-inducing, positive feedback effects of estrogen in female rodents (2,11). In sheep, 
kisspeptin neurons in both the arcuate (ARC) and preoptic area (POA) appear to participate in the 
positive feedback effects of estrogen (12,13). A high percentage of kisspeptin neurons located in 
the ARC, but not in the POA, co-express neurokinin B (NKB) and dynorphin (14) and were thus 
given the name “KNDy neurons.” 
 
Like kisspeptin, mutations in NKB or its cognate receptor, neurokinin receptor 3 (NK3R), preclude 
pubertal development and lead to hypogonadotropic hypogonadism in humans (15). Subsequent 
65 
 
work focused on the role of NKB in control of GnRH pulses (16–19), but there has been much less 
attention paid to the possible role of NKB in regulating the GnRH/LH surge. We have previously 
demonstrated that senktide, an NK3R agonist, acts  in the retrochiasmatic area (RCh) of the ovine 
hypothalamus to elicit a surge-like increase in LH (20,21). Furthermore, pharmacologic blockade 
of NK3R signaling within the RCh reduced the amplitude of the LH surge by approximately 50% 
(21). This finding demonstrates that NK3R activation in the RCh is essential for full expression of 
the preovulatory LH surge. Interestingly, administration of microimplants containing senktide into 
the RCh induced an increase in c-Fos expression in kisspeptin neurons located in the ARC (22). 
Since neurons in the RCh project directly to KNDy neurons (22), we propose that NK3R neurons 
in the RCh innervate KNDy neurons in the ARC and provide a circuit by which NKB acts in the 
RCh to stimulate kisspeptin release, culminating in the GnRH and LH surge in ewes.  
 
While the LH surge is critical for ovulation in females, it typically does not occur in normal males 
of many species, including rodents (23), sheep (24), and humans (25). Exogenous estrogen 
treatment, whether alone or preceded by progestin treatment, stimulates surge-like secretion of LH 
in ovariectomized ewes, but not in castrated rams (26). This lack of responsiveness to high levels 
of estrogen in rams is likely due to exposure to testosterone during critical developmental periods 
while in utero, leading to differentiation of neural systems critical for the LH surge (27,28). Adult 
rams express lower numbers of kisspeptin neurons in the POA and KNDy neurons in the ARC 
compared to females (29), but these neurons still contain ERα (30) and progesterone receptors (29) 
in both sexes, which indicates they still have the ability to respond to steroid feedback. These 
findings raise the possibility that sex differences in components of the NKB-NK3R signaling 
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system in the RCh could account, in part, for the inability of estrogen to induce an LH surge in 
male sheep. 
 
This study was designed to determine if sexual dimorphism exists in the circuitry by which NKB 
acts in the RCh to stimulate LH secretion. Our objectives were to test this hypothesis by 1) 
comparing the effect of senktide within the RCh on LH secretion in male and female lambs, 2) 
comparing NK3R and NKB expression throughout the POA and hypothalamus in male and female 
lambs, and 3) determining whether sex-specific differences exist in NKB close contacts onto 
NK3R-immunoreactive (ir) neurons in the RCh. To minimize sex differences in endogenous 
steroid concentrations, all studies were carried out in gonadectomized lambs that were treated with 
estradiol and progesterone implants to produce “artificial” luteal and/or follicular phases (31–33). 
 




Blackface ewe-lambs and wethers (rams castrated approximately three weeks after birth) born in 
February or March were moved from pasture to a quarantine area where they were fed cubed 
alfalfa hay for 2 weeks. They were then moved indoors to acclimate to housing within the facility 
for at least one week before surgeries. Once indoors, sheep were allowed free access to water and 
mineral blocks and were fed cubed alfalfa hay twice daily to maintain body weight. Animals were 
maintained in a light- and temperature-controlled room with the internal lighting environment 
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adjusted to mimic natural changes in day-length. Experiments were performed during the breeding 






Ovariectomies (OVX) were performed under aseptic conditions. Animals were first anaesthetized 
by i.v. injection of ketamine (7 mg/kg) and midazolam (0.3 mg/kg) and then maintained on 2% to 
5% isoflurane in oxygen. Ovarian vasculature was ligated, and the ovaries were removed via a 
mid-ventral incision. For pharmacological experiments, neurosurgeries were performed in wethers 
and immediately after OVX of females to implant 18-gauge stainless steel guide tubes into the 
RCh under general anesthesia as previously described (34). Bilateral (2.5 mm from midline) guide 
tubes for the microimplants were lowered to a point just behind the optic chiasm and 1.5 mm dorsal 
to the target site, cemented in place, and protected with a plastic cap. Animals were treated pre- 
and post-operatively as described previously (35). Briefly, dexamethasone, analgesics (carprofen 
and gabapentin), and antibiotics (ampicillin and gentamicin) were provided for neurosurgeries and 
carprofen and ampicillin given to OVX ewes. All pre- and post-operative drugs were acquired 
from Patterson Veterinary (Bessemer, AL) except gabapentin, which was compounded locally 
(McCracken Pharmacy, Waynesburg, PA). Animals were allowed to recover from surgery for at 
least 1 week before experiments were performed. 
 




We used the following well-described (32,33,35,36) steroid replacement model in both males and 
females to mimic patterns of ovarian hormones seen during the ovarian cycle: 1) luteal phase levels 
of estradiol were produced by subcutaneous (sc) insertion a single 1-cm long SILASTIC implant 
(inner diameter 0.34 cm, outer diameter 0.46 cm; Dow Corning Corp., Midland, MI, USA) 
containing estradiol; 2) follicular phase levels of estradiol were approximated with four, 3-cm long 
SILASTIC estradiol implants; and 3) luteal phase progesterone patterns were achieved by inserting 
2 Controlled Internal Drug Release (CIDR) devices (Zoetis, Parsippany, NJ) sc and leaving these 
in place for 10-14 days. Previous studies in ewes demonstrated that sc implantation of CIDRs 
resulted in levels of plasma progesterone that were similar to vaginally inserted CIDRs (31–33).  
 
Blood samples (3–4 ml) were collected by venipuncture, placed in heparinized tubes and plasma 
was stored at −20 °C until assayed for LH. All procedures were approved by the West Virginia 
University Animal Care and Use Committee and were performed in accordance with the National 




To normalize steroid milieu between sexes, both males and females were treated with estradiol 
and progesterone (CIDR) implants, as described above, that mimicked luteal phase concentrations 
of these steroids (36). To determine the effect of estradiol and progesterone treatment on LH 
secretion in wethers, a preliminary study using cross-bred Suffolk and Hampshire sheep was 
performed. On day 0, one small estradiol implant and two CIDRs were inserted sc. Eight days 
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later, blood samples were collected every 12 minutes for 4 hrs (E+P), after which CIDRs were 
removed and frequent blood samples collected the next day (E). Two days after CIDR removal, 
two new CIDRs were inserted and this process was repeated twice so that males were exposed to 
a total of three artificial luteal phases. Mean LH levels were similar in the second and third artificial 
phases (Supplemental Figure 2.1; second phase: E+P, 9.48 ± 1.99 ng/mL, E, 11.5 ± 2.0 ng/mL; 
third phase: E+P, 8.88 ± 1.20 ng/mL, E, 14.0 ± 1.22 ng/mL), therefore we limited experiments to 
two or more cycles of artificial luteal phases for subsequent studies using wethers.  
 
Are there sex differences in the effect of senktide microimplants in the RCh on LH release 
in an artificial follicular phase? 
 
Previous studies have shown that administration of senktide-containing microimplants into the 
RCh stimulates surge-like LH secretion in ewes (20,21). This experiment compared the effects of 
senktide administration within the RCh on LH secretion in young wethers (n = 7) and ewes (n = 
6) using the steroid treatment protocol described above and senktide treatments described in 
previous work (20,21). After one (ewes) or two (wethers) artificial luteal phases and at least two 
weeks post-surgery, CIDRs were removed and, the next day, blood samples were collected from 
36 minutes before to 8 hours after bilateral insertion of empty- (control) or senktide-containing 
microimplants into the RCh as previously described (21). Microimplants consisted of sterile 22-
gauge blunt-ended stainless steel hollow tubes that were cut to extend 1.5 mm beyond the 18-
gauge guide tubes. The ends of the microimplant tubing were tamped at least 60 times in crystalline 
senktide (Tocris Bioscience; Ellisville, MO) and the exterior wiped clean with sterile gauze 




Senktide-containing microimplants were inserted after three blood samples (36 minutes), left in 
place for 4 hours, and then removed and replaced with obturators to occlude guide cannulas. 
During the first 4 hours and 36 minutes of the sampling period, blood samples were collected at 
12-minute intervals. During the subsequent 4 hours, blood samples were collected at 30-minute 
intervals. At the end of the sampling period, CIDRs were reinserted, and the protocol was repeated 
using a cross-over design two weeks later so that each animal received both treatments during the 
study. At the end of the study, all animals were euthanized and tissue collected for assessment of 
guide cannula placement.  
 
Tissue collection for comparison of NK3R and NKB expression between males and females 
 
To determine whether differences exist between males and females in NK3R-containing cell 
populations and/or NKB-containing neurons, young male (n = 6) and female (n = 5) sheep at 9 to 
10 months of age received two sequential artificial luteal phases as described above. Females were 
OVX two weeks before the start of steroid treatment to allow time for mean LH levels to rise to 
that of wethers. On the eighth day of the second artificial luteal phase, CIDRs were removed and 
the following day, four 3-cm long implants containing estradiol were inserted. Eighteen hours 
later, animals were euthanized and tissue blocks were obtained as described below. Blood samples 






Hypothalamic tissue blocks were collected for immunohistochemical analysis and for histological 
examination of guide cannula placements as previously described (35). Briefly, animals were 
treated with heparin (20,000 U) 10 minutes before and at the time of euthanasia, which was 
accomplished by an intravenous overdose of sodium pentobarbital (8 to 12 mL, Euthasol; Patterson 
Veterinary, Bessemer, AL). Once respiration stopped and there was no eye-blink reflex, the animal 
was exsanguinated by cutting the carotids, and the head rapidly removed and perfused via the 
carotid arteries with 4 L of a solution containing 4% paraformaldehyde in 0.1 M phosphate buffer 
(PB) with 0.1% sodium nitrite. Tissue blocks containing the POA and hypothalamus were removed 
and stored overnight in the paraformaldehyde solution at 4°C. The following day, blocks were 
transferred to a solution containing 20% sucrose in 0.1M PB and stored at 4°C. A microtome with 
a freezing stage was used to section blocks in 45-μm increments. For the pharmacological 
experiment, every fifth section through the RCh was stained with cresyl violet and examined for 
guide cannula placement. For neuroanatomical experiments, 10 parallel series of sections (450 μm 




For detection of NK3R and NKB, dual-label immunohistochemistry was performed on a complete 
series of free-floating hemi-sections throughout the hypothalamus from each animal. All washes 
were performed at room temperature under gentle agitation with phosphate buffered saline (PBS). 
Sections were rinsed 4 times for 5 minutes between incubations unless noted otherwise. On the 
first day, tissue sections were rinsed thoroughly 12 times for 15 minutes each time. After PBS 
washes, tissue sections were incubated for 1 hour in 1% H2O2 for 10 minutes, rinsed, and incubated 
72 
 
in 20% normal goat serum (Jackson Immunoresearch, West Groove, PA) in PBS containing 0.4% 
triton X-100 (NGS) before overnight incubation with rabbit anti-NKB (dilution 1:5,000 in 4% 
NGS; Phoenix, Catalog #H-026-06, Lot 01297-2). On the second day, sections were rinsed and 
then incubated in biotinylated goat anti-rabbit immunoglobin (1:500 in 4% NGS; Vector BA-1000, 
Lot ZA0520) for 1 hour, followed by ABC-elite (1:500 in PBS; Vector Laboratory Burlingame, 
CA) for 1 hour. Sections were rinsed again and incubated for 10 minutes in biotinylated tyramine 
(TSA) (dilution 1:250; Perkin Elmer, Waltham, MA, USA) in PBS containing 3% H2O2 per 1 mL 
of solution. After rinsing, sections were incubated in DyLight green 488-conjugated to streptavidin 
(1:100 in PBS; Fisher Scientific) for 30 minutes, followed by rinses and incubation for 1 hour in 
4% NGS. Sections were incubated overnight with rabbit anti-NK3R (dilution 1:1,000 in 4% NGS; 
Novus, Catalog #NB300-102, Lot F1). On the third day, sections were rinsed and then incubated 
in Alexa555 goat anti‐rabbit (dilution 1:100 in 4% NGS; Life Technologies, Carlsbad, CA, USA) 
for 30 minutes. Sections were rinsed again before being incubated with Neurotrace 640/600 Deep 
Red Fluorescent Nissl Stain (1:100 in PBS; Life Technologies; Lot N21483) for 20 minutes. 
Sections were then rinsed in phosphate buffer (PB), mounted on charged Superfrost slides (Fisher 
Scientific), cover-slipped using Gelvatol and stored in the dark at 4°C until analyzed. 
 
Analysis of NK3R-ir cells in the POA and RCh, and NKB-ir cells in ARC: 
 
The total number of NK3R-ir cells in the POA and RCh, and the average number of NKB-ir 
cells/section in the ARC were assessed using an upright fluorescent microscope (VS120; Olympus, 
Tokyo, Japan) with a 20x objective. The total number of NK3R-ir cells represents the sum of cell 
numbers in three representative POA hemi-sections that included, or were just posterior to, the 
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organum vasculosum of lamina terminalis (33,38).  The area analyzed in the RCh extended in the 
lateral direction from the fornix to the medial edge of the optic tract, dorsally from the fornix to 
the base of the brain and approximately 1.4 mm (three hemi-sections) posterior to the optic chiasm 
(33,38). NKB cell numbers were averaged across 3 – 4 hemi-sections containing the middle to 
caudal ARC per animal (14). All cell counts were made by an observer blinded to treatment groups.  
 
Analysis of NK3R-ir fibers in the ARC and NKB-ir fibers and close contacts on NK3r-ir 
neurons in the RCh: 
 
In order to assess NK3R fiber intensity in the ARC and NKB fiber intensity in the RCh, 4 images 
were captured across at least two hemi-sections per animal using a Hamamatsu Orca Flash 4.0 
monochrome cMOS camera on a Nikon A1R confocal microscope (Nikon Instruments Inc., 
Melville, NY) with a Plan Apochromat VC 20X DIC N2/ 0.8 WD (1 mm) objective. Confocal Z-
stacks of optical sections were taken at 1 µm intervals throughout each section and the settings for 
each laser (488, 561, 640) were identical across all images to allow for comparisons. NIS-Elements 
software was used for image processing by the ROI statistical tools to measure mean pixel intensity 
across a Z-stack; each image area measured 512 x 512 pixels.  A threshold signal was established 
and applied to all images before the number of objects was determined by the ROI standard. To 
examine the number of NKB close-contacts onto NK3R-containing neurons in the RCh, images of 
10 neurons were captured across at least 2 sections in the RCh for each animal using the confocal 
microscope with a 60X Oil/1.4 WD (130 µm) objective. Confocal Z-stacks of optical sections were 
taken at 1 µm intervals through each neuron. The number of close-contacts onto cell bodies was 
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analyzed using the Nikon software, NIS Elements, and orthogonal views were used to confirm that 




Radioimmunoassays for LH were performed as previously described for ovine samples (39). 
Briefly, LH concentrations were measured in duplicate using 100 – 200 μL of plasma per sample 
via a double-antibody radioimmunoassay with reagents supplied by the National Hormone and 
Peptide Program (Torrance, CA, USA). The sensitivity of the assay averaged 0.06 ng/tube, and 




In Experiment 1, 4 of 6 females and 4 of 7 males were considered to have correct RCh placements 
of guide cannulas. Animals with misplaced cannulas were omitted from statistical analysis. 
Comparison of the effect of senktide-containing microimplants to blank microimplants for the total 
sampling period or hourly time blocks was done using two-way ANOVA with repeated measures 
(influence of time and treatment within sex) with Holm-Sidak post-hoc analysis used for pairwise 
multiple comparison. The total number of NK3R cells in the POA and RCh, NK3R fiber intensity 
in the ARC, average number of NKB cells in the ARC, average number of NKB contacts onto 
NK3R-positive cells in the RCh, and NKB fiber intensity in the RCh were compared between 
sexes with independent t-tests. Data are reported as mean ± SEM. Differences were considered 






Are there sex differences in the effect of senktide microimplants in the RCh on LH release 
in an artificial follicular phase?  
 
Placement of guide cannulas is shown in Fig. 2.1A; incorrect placements were either rostral or 
caudal to the RCh. In ewes with correct placements (n = 4/sex), senktide administration into the 
RCh resulted in sustained increases in LH secretion (Fig. 2.1B). LH concentrations in response to 
senktide were significantly higher than control treatments at approximately 1 hour after drug 
administration (Fig. 2.1C) and remained significantly elevated for at least 7 hours. Mean LH 
concentrations in females for the entire sampling period after administration of senktide-containing 
microimplants was significantly higher compared to those with empty microimplants (Fig. 2.2A). 
From 0 to 1 hour, there was no significant effect of senktide on LH secretion (P = 0.20). However, 
for the remainder of the sampling period, mean LH concentration was significantly increased by 
senktide treatment in females (P ≤ 0.03) (Fig. 2.2B). In males, LH concentrations were transiently 
elevated for a total of 2 hours, starting approximately 1.5 hours after senktide administration (Fig. 
2.1C). There was no significant effect of senktide on LH secretion for the entire sampling period 
(Fig 2.2A) or from 0 to 2 hours (P ≥ 0.10) and 5 to 8 hours (P ≥ 0.20) post-implantation (Fig. 
2.2C). However, from 2 to 5 hours post-implantation of senktide-containing microimplants, LH 




Are NK3R-containing cell populations throughout the POA and hypothalamus sexually 
dimorphic?  
 
As expected, mean LH concentrations were much higher in females compared to males at the time 
of tissue collection, when an LH surge was occurring in many females, but no males (97.9 ± 38.6 
ng/mL vs 3.82 ± 0.61 ng/mL). In agreement with previous work (38), NK3R-cell populations 
throughout the POA and hypothalamus appeared morphologically distinct depending on region. In 
our observations, regardless of sex, NK3R-ir neurons in the POA (Fig. 2.3A – D) were bipolar, 
parvicellular neurons that were approximately 12 µm in somal diameter, while those in the RCh 
(Fig. 2.4A – E) were larger, multipolar neurons that were greater than 20 µm in somal diameter. 
Regardless of sex or neuroanatomical area, NK3R-positive neuronal projections were long, 
fibrous, and readily visualized. The number of NK3R-ir cells in the POA (Fig. 2.3E) and RCh (Fig. 
2.4F) was greater in females than in males (POA, female 216 ± 30.7 vs male 109.5 ± 14.2 cells; 
RCh, female 133.8 ± 9.7 vs male 88.3 ± 11.4 cells).  
 
In the ARC, NKB neurons were readily visualized for both sexes in the middle to caudal ARC and 
presented with parvicellular morphology typical of KNDy neurons (Fig. 2.5A and B). NK3R-
expressing cells were highly dense in the middle to caudal ARC irrespective of sex. The majority 
of NK3R staining was punctate, in contrast to NK3R-ir in the POA and RCh, where staining was 
largely cytoplasmic and cell bodies were more readily visible. Additionally, nearly all NKB cells 
had close contacts with NK3R-positive fibers and a high number of NK3R varicosities were visible 
in the ARC.  There was no difference between sexes in NK3R-positive mean fiber intensity in the 
ARC (females, 24,888 ± 8,468 intensity units; males, 31,799 ± 8,855 intensity units). The average 
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number of NKB neurons in the ARC was greater in females than in males (Fig. 2.5C; female 60.9 
± 4.2 vs male 24.3 ± 3.6 cells) which is in agreement with what is previously described in adults 
(29,30,40) and prenatal testosterone-treated females (30,33). 
 
Are NKB projections to the RCh sexually dimorphic? 
 
As illustrated by representative photomicrographs in Figure 2.6, there was a greater number of 
NKB-ir inputs to NK3R-containing neurons in the RCh in females than in males (4.59 ± 1.16 
contacts/cell vs. 0.41 ± 0.32 contacts/cell) and this was reflected in less overall NKB-ir in this 
region: mean pixel intensity for NKB staining was greater in females compared to males (5,831 ± 




These data provide evidence for differences within the RCh that may contribute to the sexual 
dimorphism of the estrogen-induced LH surge in sheep. Several studies have demonstrated the 
importance of NKB-NK3R signaling in the RCh and the potential for this system to play a role in 
surge-like LH release by acting via KNDy neurons in the ARC in females (13,20–22), but this 
system has not been examined in males. In the current study, we showed that senktide 
administration in the RCh resulted in continuous, surge-like LH release in female, but not male, 
sheep. Moreover, we demonstrated that the number of NK3R-containing neurons in the RCh and 
the number of NKB inputs per NK3R cell in the RCh was greater for females than males when 
both were exposed to levels of estradiol sufficient for surge generation in females. These results 
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point to the RCh as a site of functional and morphological sex differences in NKB-NK3R 
signaling.  
 
We observed obvious differences in the patterns of LH release in response to RCh senktide 
administration between males and females. In agreement with previous findings (21,22), LH 
release following administration of senktide in the RCh was elevated and prolonged in females. 
This pattern of LH secretion is more typical of an LH surge, which lasts approximately 12 hours 
in sheep (41), than episodic LH secretion, and supports the hypothesis that NKB activity within 
the RCh is important for the LH surge in females. In contrast, while increased LH release was 
evident in males, this elevation was transient, lasting only about 2 hours. In addition to prolonged 
LH release, the onset of the LH response to senktide occurred sooner in females compared to 
males. While the percent increase in mean LH concentrations after senktide administration was 
higher in females than in males (~160% vs 47%), the absolute change in LH concentrations was 
similar (both ~9 ng/mL). Comparison of these changes is complicated by the fact that baseline LH 
concentrations in wethers were much higher than in OVX females. This is surprising because such 
differences were not seen in the preliminary study or in the wethers from which tissue was 
collected for analysis of NK3R and NKB expression. Nonetheless, while the immediate response 
to senktide may have been quantitatively similar between males and females, the long-term 
response was clearly not. The simplest explanation for this sexual dimorphism is that NK3R-ir 
neurons residing within the RCh are more numerous in females than in males. Thus, this population 
would be expected to be more readily activated and able to produce a quicker response. The more 
prolonged response in females may also be due to more numerous NK3R-ir neurons in the RCh or 
the greater number of KNDy neurons in the ARC of females because activation of the former acts 
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through ARC kisspeptin release to influence LH secretion (22).  Regardless, the temporal 
differences between the sexes in response to senktide provide functional evidence for sexual 
dimorphism in NKB-NK3R signaling in the RCh of sheep.  
 
This is the first evidence in sheep that activation of NK3R can stimulate LH secretion in males.  
However, there is evidence in monkeys that NK3R signaling can increase LH release in males. 
Specifically, NKB or senktide injected as an intravenous bolus elicited a robust discharge of LH 
from GnRH-primed pituitary juvenile male monkeys (42). Furthermore, this LH release was 
abolished by pre-treatment with a GnRH-R antagonist, establishing the GnRH dependency of the 
induced LH release, and indicating that the site of action of the NK3R agonists. Repetitive 
activation of NK3R in these monkeys failed to sustain robust pulsatile GnRH release, unlike the 
effect of repetitive activation of KISS1R (42). In contrast, recent studies of male mice 
demonstrated that intraperitoneal and intracerebroventricular administration of NKB was not 
associated with LH release (43). It should also be pointed out that the effects of NKB and/or 
senktide in male sheep and monkeys indicate that NK3R signaling can increase LH, but the 
physiological importance of this await studies with NK3R antagonists.  
 
In this study, we observed that the total number of NK3R-containing cells in the POA and RCh 
was lower in males than females when tissue was collected in the presence of surge-inducing levels 
of estradiol. This is in contrast to what is found in prenatal testosterone-treated females (33), in 
which no effect of testosterone treatment on the number of NK3R-containing cells was found for 
either the POA or RCh. These apparently contradictory results are likely not due to differences in 
hormonal milieu because tissue was collected during an “artificial follicular phase” in both studies. 
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Instead they are most likely explained by differences in animal models because females born to 
testosterone-treated mothers still exhibit some aspects of female reproductive function, including 
a blunted LH surge, for at least two years after birth (27,44). Thus, lambs born to prenatally 
testosterone-treated females may represent an intermediate neuroanatomical state between normal 
males and females. This possibility is consistent with the report of Cheng et al., (29) that prenatal 
testosterone treatment failed to reduce the number of kisspeptin-ir cells in the ARC to levels 
comparable to that seen in normal male brains (29).  
 
In contrast to NK3R expression in the RCh and POA, the observation that the number of NKB 
cells in the ARC is higher in young females compared to young males is in agreement with 
previous results in young and adult intact rams (30,40) and prenatally testosterone-treated females 
(33). In the ARC, mean NK3R fiber intensity did not differ between males and females. This is in 
contrast with an earlier report of a small decrease in NK3R-ir cells in prenatally testosterone-
treated females (31), and may reflect the likelihood that many of these fibers arise from neurons 
outside the ARC.  We did not assess NK3R-ir in ARC NKB cells because it was difficult to 
accurately distinguish between NK3R-ir bound to the cell membrane from NK3R-ir close contacts 
due to the punctate nature of this staining.  
 
We observed dramatic sex differences in the extent of NKB-ir fibers and NKB-containing inputs 
onto NK3R-ir cells in the RCh, both of which were approximately four times greater in females 
than in males. The presence of NKB-containing fibers in the RCh is in agreement with previous 
findings in female sheep (38). However, the origin of these fibers is unknown. In sheep, nearly all 
NKB-ir neurons are located in the ARC (30,45), and the vast majority of these neurons also contain 
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kisspeptin (14). However, these KNDy neurons do not project to the RCh because few, if any, 
kisspeptin-ir fibers are seen in this region (9). There is evidence that some cells in the ARC project 
to the RCh, but these cells did not colocalize with kisspeptin (22). Thus, the source of the NKB 
inputs seen in the RCh could be the small population of NKB neurons in the ARC that do not co-
express kisspeptin (14) or other NKB-producing cells that cannot be detected by 
immunohistochemistry because the peptide is rapidly transported to terminals. Further studies 
using other approaches such as in situ hybridization are needed to distinguish between these two 
possibilities. 
 
The decreased NKB/NK3R signaling found in males may underlie the sexual dimorphism in both 
the response to senktide and the failure of males to produce GnRH/LH surges. The decreased 
number of NK3R-containing neurons in the RCh of males provides a simple explanation for the 
attenuated LH response to local administration of senktide in this area. However, the ability of 
senktide to increase LH secretion in males indicates that differences in NK3R expression cannot 
account, by itself, for the lack of an estrogen-induced LH surge. Thus, one can infer that the 
decrease in NKB input to this region in males likely contributes to the sexual dimorphism in 
estrogen positive feedback in sheep. These findings also support the hypothesis that the population 
of NK3R-containing cells in the RCh is necessary for full expression of the LH surge in females 
(21). These cells are thought to increase GnRH/LH secretion during a surge by activating release 
of kisspeptin from KNDy cells in the ARC (22). Thus, the lower number of KNDy cells in the 
ARC of males could also contribute to the sexual dimorphism seen in the inability of males to 




In summary, we report morphological and functional evidence of sexual dimorphism in NKB-
NK3R signaling in the ovine RCh. Senktide administration in the RCh resulted in prolonged, 
surge-like LH release in female, but not male, sheep. This finding is associated with fewer NK3R-
positive cells and NKB contacts onto NK3R-containing cells in the RCh, and fewer NKB cells in 
the ARC of males. Therefore, we propose that deficiencies in NKB inputs to the RCh, the response 
to NKB in the RCh, and in the ability of KNDy neurons to respond to a stimulus from the RCh all 
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Figure Legends  
 
Figure 2.1. Effect of microimplants containing senktide or blank (control) implants in the RCh on 
LH secretion during an artificial follicular phase in female and male sheep (n = 4/group). (A) Guide 
cannula placement in the RCh. Grey circles represent guide cannula placements in males while 
white circles represent guide cannula placements in females. (B) Individual LH profiles in a female 
and male sheep with either blank (closed circle) or senktide-containing (open circle) microimplants 
in the RCh. Microimplants were inserted at time 0. (C) Mean LH concentrations for each group. 
*First sample that was significantly greater than controls following senktide treatment. 
 
Figure 2.2. Effect of blank (control) microimplants or microimplants containing senktide in the 
RCh on LH secretion during an artificial follicular phase in female and male sheep. (A) Mean LH 
levels for the 8 hrs after insertion of microimplants into the RCh in males and females.  Mean LH 
response in females (B) and males (C) during hourly time intervals after administration of blank 
or senktide-containing microimplants into the RCh (two-way ANOVA with repeated measures, 
n=4/group; p < 0.05* vs control treatment).  
 
Figure 2.3. NK3R immunoreactivity in the POA of female and male sheep. Panels A and B present 
low magnification images illustrating NK3R (red) immunoreactivity and NeuroTrace 640/660 
fluorescent Nissl staining (blue) in the POA of a female and male sheep, respectively. Higher 
magnification images of areas identified by the dashed, white boxes are presented in Panels C 
(female sheep) and D (male sheep). Scale bar in A, B = 200 µm. Scale bar in C, D = 100 µm. 
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Arrows indicate some NK3R-containing cells. (E) Bar graphs compare the total number of NK3R-
ir neurons in the POA of female and male sheep (p < 0.05* vs male).  
 
Figure 2.4. NK3R immunoreactivity in the RCh of female and male sheep. Panels A and B present 
low magnification images illustrating NK3R (red) immunoreactivity and Nissl staining (blue) in 
the RCh of a female and male sheep, respectively. Higher magnification images of areas identified 
by the dashed, white boxes are presented in Panels C (female sheep) and D (male sheep). (E) 
Confocal image (1 µm optical section) of a NK3R-containing cell in the RCh of a female sheep. 
Scale bars: A, B = 500 µm; C, D = 100 µm; E = 50 µm. Arrows indicate some NK3R containing 
cells. (F) Bar graphs compare the total number of NK3R-ir neurons in the RCh of female and male 
sheep (p < 0.05* vs male).  
 
Figure 2.5. NKB immunoreactivity in the ARC of female and male sheep. (A) Left: 
Photomicrograph illustrating NKB (green) immunoreactivity and Nissl staining (blue) in the ARC 
of a female (A) and male (B) sheep. Scale bar = 100 µm. Arrows indicate some NKB cells. (C) 
Right: The average number of NKB neurons in the ARC of female and male sheep (p < 0.05* vs 
male).   
 
Figure 2.6. NKB and NK3R immunoreactivity in the RCh of female and male sheep. 
Photomicrographs of confocal images (1 µm thick optical section) illustrating NKB (green), Nissl 
staining (blue), and NK3R (red) in the RCh of female (A) or male (B) sheep. Thin yellow line in 
merged images (bottom left panel) represents cursor tool used to examine cell contacts by 




Supplemental Figure 2.1. Steroid-induced suppression of LH secretion in wethers. Phase 0 
represents pre-treatment mean LH levels in the absence of steroids. At day 0, one small (1 cm) 
Silastic-brand implant containing estradiol was inserted sc and remained in place for the entire 
experiment period. Two progesterone-containing CIDRs were also inserted sc at this time (E+P; 
Phase I). Eight days later, CIDRs were removed, while the small estrogen implant was left in place 
(E; Phase I). Two days later, new CIDRs were inserted and left in place for eight days (E+P; Phase 
II); this process was repeated for a total of three artificial luteal phases. Mean LH levels were 
similar between respective E+P and E periods for the second and third artificial phases by ANOVA 
with repeated measures and Dunnett’s test (different letters over bars indicate statistically 
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The neuropeptides neurokinin B (NKB) and kisspeptin are critical for fertility in humans and 
potent stimulators of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH) 
secretion in primates and sheep. We previously obtained evidence that NKB actions in the 
retrochiasmatic area (RCh), acting via kisspeptin release from kisspeptin neurons in the arcuate 
nucleus (ARC), are important for the LH surge in sheep. One important characteristic of the LH 
surge in many species is that it is sexually dimorphic. We demonstrated sexual dimorphism in 
NK3R-NKB signaling in the preoptic are (POA), RCh, and ARC by comparing tissue from wethers 
and ovariectomized females. In this study, we extended that work to determine if a 
neuroanatomical basis exists for this sexual dimorphism in acutely gonadectomized animals by 
characterizing sex differences in expression of NK3R-, NKB-, and kisspeptin-containing neurons 
the hypothalamus. To normalize steroid milieu, rams and ewes (9 – 10 months, n=5/group) of a 
similar age were gonadectomized and treated with estradiol and progesterone (CIDR) implants 
that mimicked luteal phase concentrations of these steroids. After one (female) and two (male) 
artificial luteal phases, CIDRs were removed and LH surge-inducing levels of estradiol were 
administered via subcutaneous implants. Animals were sacrificed the following day and 
hypothalamic blocks were removed for immunohistochemical and microscopic analysis. In the 
ARC, the total number of NKB and kisspeptin neurons were higher in females than males, but no 
difference was observed in the percentage of NKB or kisspeptin cells that colocalized with NK3R. 
There was no difference between the number of NK3R-containing neurons in the POA between 
females and males, however, a significantly greater number of NK3R-ir cells in the RCh was 
observed in females. Furthermore, the number of NKB inputs to NK3R-containing cells in the 
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RCh was greater in females compared to males. These data provide evidence for a sexual 
dimorphism in the neuroanatomical basis for the LH surge and indicate that the sexual dimorphism 






The neuroendocrine pathways that control ovulation in females have been the subject of intense 
investigation over the last fifty years (1–5). High levels of estradiol produced by the maturing 
follicle(s) act to induce a GnRH surge that in turn elicits a corresponding surge of LH, which then 
causes ovulation. The molecular and neural mechanisms that mediate the interplay between 
estrogen and GnRH are still not fully understood. Because GnRH neurons are devoid of estrogen 
receptor alpha (ERα) (6), the receptor subtype whereby estrogen exerts its effects, intermediary 
neurons must participate in this process.  
 
The role of kisspeptin in controlling GnRH secretion has been extensively examined since 
kisspeptin signaling was shown to be critical for fertility in humans (7,8) and mice (8). Importantly, 
kisspeptin neurons express ERα in numerous species (9), including sheep (10), supporting the 
likelihood of a direct effect of estrogen on these neurons. Recently, it has been demonstrated that 
a population of kisspeptin neurons in the rostral periventricular area of the third ventricle mediate 
the surge-inducing, positive feedback effects of estrogen in female rodents (2,11). In sheep, it 
appears that kisspeptin neurons in both the arcuate (ARC) and preoptic area (POA) participate in 
the positive feedback effects of estrogen (12,13). A high percentage of kisspeptin neurons located 
in the ARC, but not in the POA, co-express neurokinin B (NKB) and dynorphin (14) and were 
thus given the name “KNDy neurons.” 
 
Like kisspeptin, mutations in NKB or its cognate receptor, neurokinin receptor 3 (NK3R), preclude 
pubertal development and lead to hypogonadotropic hypogonadism in humans (15). We have 
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previously demonstrated that senktide, an NK3R agonist, acts  in the retrochiasmatic area (RCh) 
of the ovine hypothalamus to elicit a surge-like increase in LH (16,17). Furthermore, 
pharmacologic blockade of NK3R signaling within the RCh reduced the amplitude of the LH surge 
by approximately 50% (17). This finding demonstrates that NK3R activation in the RCh is 
essential for full expression of the preovulatory LH surge. Interestingly, administration of 
microimplants containing senktide into the RCh induced an increase in c-Fos expression in 
kisspeptin neurons located in the ARC (18). Because neurons in the RCh project directly to KNDy 
neurons (18), we propose that NK3R neurons in the RCh innervate KNDy neurons in the ARC and 
provide a circuit by which NKB acts in the RCh to stimulate kisspeptin release, culminating in the 
GnRH and LH surge in ewes.  
 
While the LH surge is critical for ovulation in females, it typically does not occur in normal males 
in many species, including rodents (19), sheep (20), and humans (21). Exogenous estrogen 
treatment, whether alone or preceded by progestin, readily stimulates surge-like secretion of LH 
in ovariectomized ewes, but not in castrated rams (22). This lack of responsiveness to high levels 
of estrogen in rams is likely due to exposure to testosterone during critical developmental periods 
in utero; leading to differentiation of neural systems critical for the LH surge (23,24). Adult rams 
have lower numbers of kisspeptin neurons in the POA and KNDy neurons in the ARC compared 
to females (25), but these neurons contain ERα (26) and progesterone receptors (25) in both sexes, 
indicating they still have the ability to respond to steroid feedback. Moreover, these differences in 
kisspeptin expression are not seen in females that were treated prenatally with androgens (25,27) 
and could thus reflect differences in steroid negative feedback between gonadally-intact males and 
females. Furthermore, marked sex differences are observed between female and male (wethers) 
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lambs, including fewer NK3R-positive cell numbers in, and NKB inputs to, the RCh (Chapter 2). 
These results support the proposal that organizational effects of steroids result in a combined 
reduction in ligand and receptor components of KNDy/NK3R signaling. However, differences 
between long-term castrated males (wethers) and short-term ovariectomized (OVX) females might 
also account for some of these differences.  
 
This study was designed to determine if sexual dimorphism exists in the RCh and ARC of acutely 
gonadectomized male and female sheep. To test this hypothesis we compared NK3R, NKB, and 
kisspeptin expression throughout the hypothalamus in male and female lambs during 
administration of surge-inducing levels of estrogen. To minimize sex differences in endogenous 
steroid concentrations, all studies were carried out in gonadectomized lambs that were treated with 
estradiol and progesterone implants to produce “artificial” luteal and/or follicular phases (27–29). 
This design also allowed us to determine if sexual dimorphism in NK3R, NKB, and kisspeptin 
expression is a result of organization or activational (direct effects in adults) actions of sex steroids. 
 




Blackface ewe- and ram-lambs born in February or March were moved from pasture to a 
quarantine area where they were fed Timothy Pellets (Standlee Hay Company, Inc., 22349 
Kimberly Road, Kimberly, ID) and Triple Crown Complete Pellets (Triple Crown, 315 Lake Street 
East, Wayzata, MN) for 2 weeks. They were then moved indoors to acclimate to housing within 
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the facility for at least one week before surgeries. Once indoors, sheep were allowed free access 
to water and mineral blocks and were fed twice daily with Timothy Pellets and Triple Crown to 
maintain body weight. Animals were maintained in a light- and temperature-controlled facility 
with the internal lighting environment adjusted to mimic natural changes in day-length. 
Experiments were performed during the breeding season (December), when animals were 9 to 10 
months of age. All procedures were approved by the West Virginia University Animal Care and 
Use Committee and were performed in accordance with the National Institutes of Health guidelines 






Ovariectomies (OVX) were performed under aseptic conditions. Animals were first anaesthetized 
by i.v. injection of ketamine (7 mg/kg) and midazolam (0.3 mg/kg) and then maintained on 2% to 
5% isoflurane in oxygen. Ovarian vasculature was ligated, and the ovaries were removed via a 
mid-ventral incision. Castrations (CAST) were performed using the local anesthetic, bupivacaine. 
Rams were first injected with bupivacaine into each spermatic cord. The distal third of the scrotal 
sac was removed using a scalpel and connective tissue was dissected from each spermatic cord to 
visualize the vessels. These vessels were crushed with an emasculator (pressure applied for 2 – 4 
minutes), the vessels were tied off with a transfixing ligature proximal to the emasculator. The 
vessels were then cut distal the emasculator, and the testes and emasculators were removed. The 
castration site was sprayed with Blu-Kote antibacterial spray and left open to drain. Carprofen and 
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ampicillin were immediately given to animals and Butorphanol (0.05 mg/kg SQ) or Banamine (2 
mg/kg IV) were given as needed to alleviate pain. All pre- and post-operative drugs were acquired 
from Patterson Veterinary (Bessemer, AL).  
 
Steroid replacement and blood sampling procedures 
 
We used the following well-described (27,29–31) steroid replacement model in both males and 
females to mimic patterns of ovarian hormones seen during the ovarian cycle: 1) luteal phase levels 
of estradiol were produced by subcutaneous (sc) insertion a single 1-cm long SILASTIC implant 
(inner diameter 0.34 cm, outer diameter 0.46 cm; Dow Corning Corp., Midland, MI, USA) 
containing estradiol; 2) follicular phase levels of estradiol were approximated with four, 3-cm long 
SILASTIC estradiol implants; and 3) luteal phase progesterone patterns were achieved by inserting 
2 Controlled Internal Drug Release (CIDR) devices (Zoetis, Parsippany, NJ) sc and leaving these 
in place for 10-14 days. Previous studies in ewes demonstrated that sc implantation of CIDRs 
resulted in levels of plasma progesterone that were similar to vaginally inserted CIDRs (27–29).  
 
Blood samples (3–4 ml) were collected by venipuncture, placed in heparinized tubes and plasma 
was stored at −20 °C until assayed for LH.  
 





We first confirmed that there was a sexual dimorphism in estrogen positive feedback in these 
sheep. Both males and females were treated with estradiol and progesterone (CIDR) implants, as 
described above, that mimicked luteal phase concentrations of these steroids (30). Young male (n 
= 5) and female (n = 5) sheep at 9 to 10 months of age received one (females) and two (males) 
artificial luteal phases before the administration of surge-inducing levels of estrogen; males 
received an additional artificial luteal phase to ensure that LH was suppressed to a level similar to 
females. On the eighth day of the first (females) and second (males) artificial luteal phase, CIDRs 
were removed and the following day, four 3-cm long implants containing estradiol were inserted. 
In order to encompass the entire LH surge, blood samples were collected every 4 hours for 40 
hours to assess LH concentrations.  
 
Tissue collection for comparison of NK3R, NKB, and kisspeptin expression between males 
and females 
 
We next used these same animals to determine whether differences exist between males and 
females in NK3R-containing cell populations and/or NKB- and kisspeptin-containing neurons. At 
the end of the previous experiment, the four long estradiol implants were removed and two new 
CIDRs inserted. Eight days later, blood samples were collected every 12 minutes for 4 hours to 
assess LH concentration in the presence of luteal phase levels of progesterone (P). After sampling, 
CIDRs were removed and the following day, blood samples were collected every 12 minutes for 
1 hour to assess LH concentrations in the presence of follicular phase levels of estradiol (E). After 
sampling, four 3-cm long implants containing estradiol were inserted. Approximately 18 to 20 
hours later, animals were euthanized and tissue blocks were obtained as described below. Blood 
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samples were collected every 12 min for 1 hour just before tissue collection to assess LH 




Hypothalamic tissue blocks were collected for immunohistochemical analysis as previously 
described (31). Briefly, animals were treated with heparin (20,000 U) 10 minutes before and at the 
time of euthanasia, which was accomplished by an intravenous overdose of sodium pentobarbital 
(8 to 12 mL, Euthasol; Patterson Veterinary, Bessemer, AL). Once respiration stopped and there 
was no eye-blink reflex, the animal was exsanguinated by cutting the carotids, and the head rapidly 
removed and perfused via the carotid arteries with 4 L of a solution containing 4% 
paraformaldehyde in 0.1 M phosphate buffer (PB) with 0.1% sodium nitrite. Tissue blocks 
containing the POA and hypothalamus were removed and stored overnight in the 
paraformaldehyde solution at 4°C. The following day, blocks were transferred to a solution 
containing 20% sucrose in 0.1M PB and stored at 4°C. A microtome with a freezing stage was 
used to section blocks in 45-μm increments and 10 parallel series of sections (450 μm apart) were 




For detection of NK3R, NKB, and kisspeptin, dual-label immunohistochemistry was performed 
on a complete series of free-floating hemi-sections throughout the hypothalamus from each animal. 
All washes were performed at room temperature under gentle agitation with phosphate buffered 
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saline (PBS). Sections were rinsed 4 times for 5 minutes between incubations unless noted 
otherwise. On the first day, tissue sections were rinsed thoroughly 12 times for 15 minutes each 
rinse. After PBS washes, tissue sections were incubated for 1 hour in 1% H2O2 for 10 minutes, 
rinsed, and incubated in 20% normal goat serum (NGS; Jackson Immunoresearch, West Groove, 
PA) in PBS containing 0.4% triton X-100 before overnight incubation with rabbit anti-NKB 
(dilution 1:5,000 in 4% NGS; Phoenix, Catalog #H-026-06, Lot 01297-2) or rabbit anti-kisspeptin 
(dilution 1:50,000 in 4% NGS; Caraty: AC566). On the second day, sections were rinsed and then 
incubated in biotinylated goat anti-rabbit immunoglobin (1:500 in 4% NGS; Vector BA-1000, Lot 
ZA0520) for 1 hour, followed by ABC-elite (1:500 in PBS; Vector Laboratory Burlingame, CA) 
for 1 hour. Sections were rinsed again and incubated for 10 minutes in biotinylated tyramine (TSA) 
(dilution 1:250; Perkin Elmer, Waltham, MA, USA) in PBS containing 3% H2O2 per 1 mL of 
solution. After rinsing, sections were incubated in DyLight green 488-conjugated to streptavidin 
(1:100 in PBS; Fisher Scientific) for 30 minutes, followed by rinses and incubation for 1 hour in 
4% NGS. Sections were incubated overnight with rabbit anti-NK3R (dilution 1:1,000 in 4% NGS; 
Novus, Catalog #NB300-102, Lot F1). On the third day, sections were rinsed and then incubated 
in Alexa555 goat anti‐rabbit (dilution 1:100 in 4% NGS; Life Technologies, Carlsbad, CA, USA) 
for 30 minutes. Sections were rinsed again before being incubated with Neurotrace 640/600 Deep 
Red Fluorescent Nissl Stain (1:100 in PBS; Life Technologies; Lot N21483) for 20 minutes. 
Sections were then rinsed in phosphate buffer (PB), mounted on charged Superfrost slides (Fisher 
Scientific), cover-slipped using Gelvatol and stored in the dark at 4°C until analyzed. 
 
Analysis of NK3R-ir cells in the POA and RCh, NKB-ir and kisspeptin-ir cells in ARC, and 




The total number of NK3R-ir cells in the POA and RCh, and the average number of NKB-ir and 
kisspeptin-ir cells/section in the ARC were assessed using an upright fluorescent microscope 
(VS120; Olympus, Tokyo, Japan) with a 20x objective. The total number of NK3R-ir cells 
represents the sum of cell numbers in three representative POA hemi-sections that included, or 
were just posterior to, the organum vasculosum of lamaina terminalis. In the RCh, the total number 
of NK3R-ir cells represents the sum of cell numbers in three representative sections that extended 
in the lateral direction from the fornix to the medial edge of the optic tract, dorsally from the fornix 
to the base of the brain and approximately 1.4 mm (three hemi-sections) posterior to the optic 
chiasm (27,33). NKB and kisspeptin cell numbers and the percentage that colocalized with NK3R 
were averaged across 3 – 4 hemi-sections containing the middle to caudal ARC per animal (14). 
All cell counts were made by an observer blinded to treatment groups.  
 
 
Analysis of NKB-ir close contacts on NK3r-ir neurons in the RCh: 
 
In order to examine the number of NKB close-contacts onto NK3R-containing neurons in the RCh, 
images of 10 neurons were captured across at least 2 sections in the RCh for each animal using the 
confocal microscope with a 60X Oil/1.4 WD (130 µm) objective. Confocal Z-stacks of optical 
sections were taken at 1 µm intervals through each neuron. The number of close-contacts onto cell 
bodies was analyzed using the Nikon software, NIS Elements, and orthogonal views were used to 






Radioimmunoassays for LH were performed as previously described for ovine samples (34). 
Briefly, LH concentrations were measured in duplicate using 100 – 200 μL of plasma per sample 
via a double-antibody radioimmunoassay with reagents supplied by the National Hormone and 
Peptide Program (Torrance, CA, USA). The sensitivity of the assay averaged 0.06 ng/tube, and 




The total number of NK3R cells in the POA and RCh, the average number of NKB or kisspeptin 
cells in the ARC, the percentage of NKB or kisspeptin cells that colocalized with NK3R in the 
ARC, and the average number of NKB contacts onto NK3R-positive cells in the RCh were 
compared between sexes with independent t-tests. Data are reported as mean ± SEM. Differences 




Administration of surge-inducing levels of estrogen to male and female gonadectomized 
lambs 
 
As expected, only females were capable of generating an LH surge after exposure to surge-
inducing levels of estrogen. For females, the average peak was 64.1 ± 7.9 ng/mL and the average 
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time to peak was 23.2 ± 1.5 hours post-implantation of four, 3-cm estrogen implants (Fig. 3.1A). 
Furthermore, and as expected, the mean LH levels for the entire 40-hour sampling period were 
higher in females compared to males: 14.2 ± 1.0 versus 2.9 ± 0.6 (Fig. 3.1B).  
 
Are NK3R-containing cell populations throughout POA and RCh sexually dimorphic?  
 
As expected, mean LH concentrations were higher in females compared to males at the time of 
tissue collection, when an LH surge was occurring in many females, but no males (16.1 ± 8.6 
ng/mL vs 2.2 ± 0.3 ng/mL). No differences were observed between sexes when samples were 
collected during exposure to luteal phase levels of estrogen and progesterone or during exposure 
to only low levels of estrogen (Fig. 3.2) 
 
In agreement with previous work (33), NK3R-cell populations throughout the POA and 
hypothalamus appeared morphologically distinct depending on region. NK3R-containing cells 
presented with morphology similar to what is described in Chapter 2. There was no difference in 
the number of NK3R-ir cells in the POA (Fig. 3.3A) between sexes (female 151.4 ± 20.5 vs male 
110.8 ± 16.3 cells) but there were more NK3R-ir cell in the RCh (Fig. 3.3B) in females than in 
males (81.8 ± 10.3 vs 55.6 ± 7.5 cells; p = 0.03).  
 
Does sexual dimorphism exist in the population of NKB-ir and kisspeptin-ir cells or the 




In agreement with previous work (33), a significantly greater number of NKB neurons was 
observed within the ARC of females compared to males: 37.5 ± 4.1 versus 8.1 ± 1.1 (p < 0.05) 
(Fig. 3.4C). No difference was observed in the percentage of NKB cells that colocalized with 
NK3R: females 44.6 ± 2.9% versus males 34.1 ± 10.1% (p = 0.18). Kisspeptin neurons were 
readily visualized for both sexes in the middle to caudal ARC and presented with parvicellular 
morphology typical of KNDy neurons (Fig. 3.4A). There was a significantly greater number of 
kisspeptin cells in the ARC of females compared to males (Fig. 3.4B). NK3R-expressing cells 
were highly dense in the middle to caudal ARC irrespective of sex. Nearly all kisspeptin cells were 
contacted by NK3R-positive fibers and a high number of NK3R varicosities were visible in the 
ARC. The percentage of kisspeptin cells that colocalized with NK3R was similar between sexes: 
females 16.1 ± 3.8% versus males 14.8 ± 3.5%.  
 
Are NKB projections to the RCh sexually dimorphic? 
 
As illustrated by representative photomicrographs in Figure 3.5, there was a greater number of 
NKB-ir inputs to NK3R-containing neurons in the RCh in females than in males (3.67 ± 0.76 








In the present study we characterized the expression of NK3R throughout the POA and 
hypothalamus and NKB inputs to NK3R-containing cells in the RCh of acutely gonadectomized 
male and female sheep. We also examined kisspeptin and NKB immunoreactivity and the degree 
of NK3R colocalization with each peptide within the ARC. We demonstrated that NK3R 
immunoreactivity and the number of NKB inputs per NK3R cell in the RCh, and kisspeptin and 
NKB immunoreactivity in the ARC was greater in gonadectomized females compared to males 
that were both exposed to levels of estradiol sufficient for surge generation in females. In 
conjunction with data previously reported (Lopez et al., 2018 - Chapter 2), these data provide 
further evidence for differences within the RCh that may contribute to the sexual dimorphism of 
the estrogen-induced LH surge in sheep. Thus the RCh and ARC are likely sites of morphological 
sexual dimorphism associated with the control of GnRH secretion.   
 
As expected, we observed differences in the patterns of LH release between gonadectomized males 
and females (20). Specifically, only females were capable of generating LH surges after 
implantation of surge-inducing levels of estradiol. In contrast, no sex differences were observed in 
LH levels between males and females during exposure to luteal phase levels of estradiol and 
progesterone or only low levels of estradiol. This contrasts with the data in Chapter 2 and indicates 
that the sexual dimorphism observed in the RCh and ARC does not correlate with sex differences 
in steroid negative feedback. As previously mentioned, a major sex difference that exists between 
males and females is the LH surge, which is programmed largely during gestation in males as a 




In this study we observed that the total number of NK3R-containing cells in the POA did not differ 
between sexes after administration of surge-inducing levels of estradiol. This is in contrast to what 
was observed in Chapter 2 in wethers, but in agreement with what was observed in prenatal-
testosterone-treated females (27). One simple explanation for this discrepancy is that the prolonged 
absence of androgens decreased NK3R expression in wethers. However the difference between 
these two studies reflect the number of NK3R-ir cells observed in females. In the earlier report, 
the number of NK3R-ir cells in the POA was 216 ± 30.7 cells in females compared to 109.5 ± 14.2 
cells in wethers. In the present report, when tissue was stained using the same protocol as in the 
previous study, the number of NK3R-ir cells in the POA was 151.4 ± 20.5 cells in females 
compared to 110.8 ± 16.3 cells in wethers. This difference in the number of NK3R-ir cells observed 
in females between studies is potentially due to higher levels of LH observed at the time of tissue 
collection. In the previous study, the mean LH concentration at the time of tissue collection in 
females was 78.8 ± 35.2 ng/mL compared to 16.1 ± 8.7 ng/mL in the current study. In contrast to 
the POA, the total number of NK3R-containing cells in the RCh was lower in males than females 
in both studies, indicating that this sexual dimorphism is independent of differences between 
wethers and acutely-castrated male sheep and thus likely related to estrogen positive feedback. As 
discussed in Chapter 2, no difference was observed in the number of NK3R-containing cells in 
prenatal testosterone-treated females compared to control females (27). Thus, lambs born to 
prenatally testosterone-treated ewes may represent an intermediate neuroanatomical state between 
those born to non-treated ewes.  
 
The number of kisspeptin cells in the ARC was higher in steroid-treated gonadectomized females 
compared to males in this study. This is in agreement with earlier reports in adults males (25).  In 
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contrast, kisspeptin cell numbers in the ARC are not affected by testosterone treatment in utero 
because androgenized females do not show reduced numbers compared to normal females when 
tissue is collected during an “artificial follicular phase” (25). The latter observations raise the 
possibility that the sexual dimorphism seen in gonadally-intact sheep was due to differences in the 
endogenous hormonal milieu, and not the organizational actions of androgens in utero. Tissue in 
this study was collected during an artificial follicular phase in both sexes, thus the differences in 
kisspeptin expression most likely reflect the organizational actions of androgens.  There are two 
possible explanations for the absence of this sexual dimorphism in prenatally androgenized ewes. 
First, and the simpler explanation, is that more prolonged exposure to androgen in utero may be 
required. Second, post-natal exposure to estradiol may play a role. Postnatal exposure to ovarian 
tissue or estradiol (for 2 years) is required for prenatally testosterone-treated females to undergo 
complete defeminization of the GnRH surge mechanism (29). The possibility exists that during 
this additional period of “differentiation,” postnatal exposure to estrogen, rather than testicular 
testosterone, within the first few months (or years) of life may influence the KNDy cell population 
in the ARC.  
 
The observation that the number of NKB cells in the ARC is higher in young females compared 
to young males is in agreement with previous results in young and adult intact rams (26,35), 
prenatally testosterone-treated females (27), and the data presented in Chapter 2. There is a 
discrepancy, however, in the number of neurons observed between the previous study and the 
current study. In Chapter 2, the number of NKB cells in the ARC was ~ 60 and 24 cells in females 
and males, respectively. In the present report, the number of NKB cells was 37.5 ± 4.1 cells in 
females, compared to 8.1 ± 1.1 cells in males. As previously discussed with the number of POA 
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NK3R-containing cells, this may be due to higher levels of LH observed at the time of tissue 
collection in the previous report. Furthermore, there is a discrepancy in the number of kisspeptin 
and NKB neurons observed in the ARC of this study. Since these are both KNDy neurons, the 
number of cells would be expected to be similar (36). A simple explanation for this observation 
can be attributed to the sensitivity of the immunofluorescent method used during the 
immunohistochemical process. For kisspeptin detection, a highly specific and validated (at the 
dose used herein) antibody was used that was generated by Alain Caraty and colleagues. This 
antibody is targeted against the C-terminal end of kisspeptin and has been shown to be specific in 
a number of species by both careful preabsorption controls (10,14,37) and the use of Kiss1 
knockout mice as negative controls (37). Although the NKB antibody used in this study has also 
been previously validated (36), either this antibody may not be as sensitive as the antibody used 
for kisspeptin detection or the immunohistochemical protocol was not yet completely optimized, 
resulting in differences in the levels of detectability in both kisspeptin and NKB. Still, the number 
of kisspeptin and NKB neurons that coexpressed NK3R in the ARC between experiments was 
similar: females, ~ 17 kisspeptin and NKB cells coexpress NK3R, and males, ~ 2 kisspeptin and 
3 NKB cells coexpress NK3R.  
 
We observed sex differences in the number of NKB-containing inputs onto NK3R-ir cells in the 
RCh. The presence of NKB-containing fibers in the RCh is in agreement with previous findings 
in female sheep (93). Furthermore, and as discussed previously, the number of NKB inputs to 
NK3R-containing neurons was greater in females compared to wethers after exposure to surge-
inducing levels of estrogen, which is similar to what was observed in this study. Thus, NKB 
innervation of the RCh, and the inputs that NK3R-containing neurons receive in this region, is 
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likely controlled by organizational effects of sex steroid during development, rather than 
activational effects during adulthood. As previously discussed, the origin of these fibers is 
unknown. In sheep, nearly all NKB-ir neurons are located in the ARC (60,120), and the vast 
majority of these neurons also contain kisspeptin (62). However, these KNDy neurons do not 
project to the RCh because few, if any, kisspeptin-ir fibers are seen in this region (194). There is 
evidence that some cells in the ARC project to the RCh, but these cells did not colocalize with 
kisspeptin (160). Thus, the source of the NKB inputs seen in the RCh could be either the small 
number of NKB neurons in the ARC that do not co-express kisspeptin (62) or other NKB-
producing cells that cannot be detected by immunohistochemistry because the peptide is rapidly 
transported to terminals.  
 
The combined decrease in both ligand (kisspeptin or NKB) and receptor (NK3R) signaling found 
in males may contribute to  the sexual dimorphism in the failure of males to produce GnRH/LH 
surges. In conjunction with an earlier report by Lopez et al., 2018, these findings support the 
hypothesis that the population of NK3R-containing cells in the RCh may be essential for full 
expression of the LH surge in females (17). These cells are thought to increase GnRH/LH secretion 
during a surge by activating release of kisspeptin from KNDy cells in the ARC (18). Thus, the 
lower number of NKB and kisspeptin cells in the ARC of males could also contribute to the sexual 
dimorphism seen in the inability of males to generate an LH surge.  
 
In summary, we report morphological evidence of sexual dimorphism in NK3R and KNDy 
signaling in the ovine RCh and ARC, respectively. Based on the observation of fewer NK3R-
positive cells and NKB contacts onto NK3R-containing cells in the RCh, and fewer NKB and 
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kisspeptin cells in the ARC of males, we propose that deficiencies in the response to NKB in the 
RCh, and in the ability of KNDy neurons to respond to a stimulus from the RCh, contribute to the 
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Figure Legends  
 
Figure 3.1. Representative LH concentrations over time for a female sheep compared to that of a 
male sheep after the administration of estrogen implants. The mean LH concentration (ng/mL) for 
the entire 40-hour sampling period is shown to the right. Asterisk indicates a significant difference 
from males (p < 0.05).  
 
Figure 3.2. Mean LH concentrations for female and male sheep during exposure to luteal phase 
levels of estrogen and progesterone (P), only low levels of estrogen (E), or surge-inducing levels 
of estrogen (EE). The high variability in the EE group is due to differences in the start of LH surges 
among individual ewes. Asterisk indicates a significant difference from males (p < 0.05).  
 
Figure 3.3. NK3R immunoreactivity in the POA and RCh of female and male sheep. Bar graphs 
compare the total number of NK3R-ir neurons in the POA and RCh of female and male sheep 
during exposure of surge-inducing levels of estradiol (p < 0.05* vs male).  
 
Figure 3.4. (A) Representative photomicrographs from a female (top row) and male (bottom row) 
sheep showing kisspeptin and Neurotrace (first; scale bar = 200 um), NK3R and Neurotrace 
(second), merged images (third), followed by a high magnification view of the area indicated by 
the white boxes (fourth; scale bar = 50 um). Co-localization in one neuron is indicated by white 
arrow. (B) Number of kisspeptin neurons in the ARC of male and female sheep (left graph) and 
the percent that colocalizes with NK3R (right graph). (C) Number of NKB neurons in the ARC of 
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male and female sheep (left graph) and the percent that colocalizes with NK3R. Asterisk indicates 
a significant difference from males (p < 0.05). 
 
Figure 3.5. NKB and NK3R immunoreactivity in the RCh of acutely-castrated female (A) and 
male (B) sheep. Photomicrographs of confocal images (1 µm thick optical section) illustrating 
NKB (green), Nissl staining (purple), and NK3R (red) in the RCh of female (A) or male (B) sheep. 
White arrowheads represent contacts. Scale bar = 50 µm. (C) Number of NKB inputs to NK3R-
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Neurokinin B (NKB) is critical for fertility in humans and stimulates GnRH/LH secretion in 
humans, primates, and sheep. We have recently demonstrated that NKB actions via its receptor, 
NK3R, in the retrochiasmatic area (RCh) contribute to surge-like LH secretion in sheep. The true 
phenotype of these NK3R-containing neurons, however, has yet to be elucidated. Based on its 
anatomical location in sheep, one potential candidate is galanin. We thus first determined if this 
neurotransmitter is found in NK3R-immunoreactive neurons in the RCh and if a sexual 
dimorphism exists in its expression within the RCh. Using dual-label immunohistochemistry, we 
observed that galanin co-localized in about 20% of RCh NK3R neurons for both male and female 
sheep. Using microinjections of the retrograde tract tracer CT into the arcuate nucleus (ARC), 
we next demonstrated that some of these galanin neurons project directly to the ARC. Furthermore, 
we assessed the effects of central galanin administration on pulsatile LH secretion and galantide 
(galanin receptor antagonist) infusion during an estrogen-induced LH surge. There was a tendency 
for galanin to stimulate LH pulse frequency during anestrus (p = 0.07) and to increase LH pulse 
amplitude during the breeding season (5 nmole dose; p = 0.06). During an estrogen-induced surge, 
galantide infusion resulted in a minor inhibitory effect on surge amplitude (approximately by 25%; 
not statistically significant) without altering the time of the LH peak. These results provide 
neuroanatomical evidence that galanin could mediate the actions of NKB in the RCh of the ewe, 











The neuroendocrine pathways that control ovulation in females have been the subject of intense 
investigation over the last fifty years (1–5). High levels of estradiol produced by the maturing 
follicle(s) act to induce a GnRH surge that in turn elicits a corresponding surge of LH, which then 
causes ovulation. The molecular and neural mechanisms that mediate the interplay between 
estrogen and GnRH are still not fully understood. GnRH neurons are devoid of estrogen receptor 
alpha (ERα) (6), the receptor subtype whereby estrogen exerts its effects, thus, intermediary 
neurons must participate in this process.  
 
Galanin, a neuropeptide widely expressed throughout the central and peripheral nervous systems 
(7,8), has been implicated in the control of GnRH release (5,9). The highest concentrations of 
galanin have been observed in the MBH of numerous species, including rats (10), primates (11), 
pigs (12), and sheep (13). In the POA, galanin is colocalized with a sub-population of GnRH 
neurons in female rats (approximately 65% of GnRH neurons) (14,15) and female primates 
(approximately 10% of GnRH neurons) (7). This population of galanin neurons also appears to be 
highly sensitive to the steroid environment in rats as, during proestrus, significantly higher levels 
of galanin are found in the POA compared to during estrus (16). Moreover, the incidence of 
colocalization of GnRH and galanin at the level of single axon terminals in the median eminence 
was dramatically decreased by ovariectomy, but this was reversed by administration of estradiol 
(17). Furthermore, galanin receptor subtype 1 (Gal-R1) has been observed in GnRH neurons in the 
POA of rats (18) and the presence of galanin close-appositions on GnRH neurons has been shown 




Galanin is released in pulses into the hypothalamus-pituitary vasculature, with much higher 
concentrations found in the portal than peripheral circulation in rodents; the majority of these 
pulses are coincident with pulses of GnRH (21). Steroid milieu appears to be important as galanin 
administration failed to suppress LH release in OVX rats, but it readily increased plasma LH levels 
in OVX rats pre-treated with estradiol benzoate (22). Furthermore, central administration of 
galantide, a non-specific galanin receptor antagonist, not only suppressed the endogenous LH 
surge, but also blunted a progesterone-induced LH surge in rats (26). Interestingly, mice with a 
genetic deletion of galanin and/or Type 2 galanin receptor (Gal-R2) remain reproductively 
competent (23–25). These findings, in conjunction with the observations that a subpopulation of 
GnRH neurons co-express  galanin in the POA and are activated during the LH surge (27), 
implicates at least a partial involvement of galanin during the LH surge in rodents.  
 
In sheep, the role of galanin in LH secretion is less characterized. Although the amount of 
colocalization between GnRH and galanin does not appear to be regulated by steroids (nearly all 
GnRH neurons in the medial POA co-express galanin) (28), galanin expression in other brain 
regions or regions of the hypothalamus may be influenced by steroid environment. This is 
supported by the findings that ERα is expressed in galanin neurons (29) and the number of galanin 
fiber close-appositions to GnRH cell bodies are increased in the presence of surge-inducing levels 
of estradiol (8). Additionally, the number of galanin-immunoreactive neurons in the caudal part of 
the POA was increased after administration of estradiol compared to controls. Galanin receptor 
subtypes 1 – 3 (Gal-R1, Gal-R2, Gal-R3) have also been detected throughout the POA, 
hypothalamus, and pituitary gland (30), and a subset of GnRH neurons have been shown to express 
135 
 
Gal-R1 mRNA (similar to what is seen in female rats) (31). Although Gal-R2 has been observed 
in a large number of neurons throughout the hypothalamus, it has not been shown to colocalize 
with GnRH in sheep (32).  
 
To date, the involvement of galanin during the LH surge has yet to be examined in sheep. We have 
previously demonstrated that senktide, a NK3R agonist, acts  in the retrochiasmatic area (RCh) of 
the ovine hypothalamus to elicit a surge-like increase in LH (33,34). Furthermore, pharmacologic 
blockade of NK3R signaling within the RCh reduced the amplitude of the LH surge by 
approximately 50% (34). This finding demonstrates that NK3R activation in the RCh is essential 
for full expression of the preovulatory LH surge. Additionally, administration of microimplants 
containing senktide into the RCh led to activation of kisspeptin neurons located in the arcuate 
nucleus (ARC) (35). Because neurons in the RCh innervate ARC kisspeptin (i.e., KNDy) neurons 
(35), we hypothesized that direct activation of ARC KNDy neurons by NK3R-containing neurons 
in the RCh plays an important role in the GnRH and LH surge of ewes. However, the phenotype 
of these NK3R-containing neurons within the RCh remains to be determined. Based on the 
anatomical distribution of galanin neurons in the ovine hypothalamus, we hypothesized that 
NK3R-containing neurons of the RCh also express galanin.  
 
This study was designed to characterize galanin neurons within the RCh and the involvement of 
galanin on LH secretion in ewes. Our specific objectives were to 1) determine if RCh galanin 
neurons contain NK3R in males and females and if RCh galanin neurons project to the ARC in 
females, 2) assess the effect of central galanin administration on LH secretion during both the 
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breeding season and anestrus, and 3) test the effect of galanin receptor blockade on the estrogen-
induced LH surge.     
     




For immunohistochemical experiments, Suffolk blackface females and wethers (rams castrated 
approximately three weeks after birth) born in February or March were used. Experiments for this 
group were performed during the breeding season (December), when animals were 9 to 10 months 
of age. For other experiments, multiparous adult ewes of mixed breeding were used. All animals 
were moved from pasture to a quarantine area where they were fed Timothy Pellets (Standlee Hay 
Company, Inc., 22349 Kimberly Road, Kimberly, ID) and Triple Crown Complete Pellets (Triple 
Crown, 315 Lake Street East, Wayzata, MN) for 2 weeks. They were then moved indoors to 
acclimate to housing within the facility for at least one week before surgeries. Once indoors, sheep 
were allowed free access to water and mineral blocks and were fed the same diet twice daily to 
maintain body weight. Animals were maintained in a light- and temperature-controlled facility 








Ovariectomies (OVX) were performed under aseptic conditions. Animals were first anaesthetized 
by i.v. injection of ketamine (7 mg/kg) and midazolam (0.3 mg/kg) and then maintained on 2% to 
5% isoflurane in oxygen. Ovarian vasculature was ligated, and the ovaries were removed via a 
mid-ventral incision. Chronic implantation of an 18-gauge needle into the third ventricle and 
microinjection of the retrograde tract tracer CT into the ARC were performed using a stereotaxic 
procedure as previously described (36,37). For the former, the cannula was cemented in place with 
dental acrylic, and the needle hub was plugged and covered with a plastic cap. CT (200 nl of a 
2% solution) was unilaterally injected into the ARC with a 1 L Hamilton syringe that extended 3 
mm beyond the end of an 18-gauge guide tube.  The injection occurred over 3 min and the needle 
was left in place for 5 min.  The needle and guide tubes were slowly withdrawn, the surface of the 
brain covered with GelFoam and the skin sutured. Animals were treated pre- and postoperatively 
with analgesics (carprofen for OVX and neurosurgeries and gabapentin for neurosurgeries) and 
antibiotics (gentamycin for OVX and neurosurgeries). All pre- and post-operative drugs were 
acquired from Patterson Veterinary (Bessemer, AL) except gabapentin, which was compounded 
locally (McCracken Pharmacy, Waynesburg, PA). Animals were allowed to recover from surgery 
for at least 1 week before experiments were performed. 
 
Steroid replacement and blood sampling procedures 
 
We used the following well-described (38–41) steroid replacement model in males and females to 
mimic patterns of ovarian hormones seen during the ovarian cycle: 1) luteal phase levels of 
estradiol were produced by subcutaneous (sc) insertion a single 1-cm long SILASTIC implant 
(inner diameter 0.34 cm, outer diameter 0.46 cm; Dow Corning Corp., Midland, MI, USA) 
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containing estradiol; 2) follicular phase levels of estradiol were approximated with four, 3-cm long 
SILASTIC estradiol implants; and 3) luteal phase progesterone patterns were achieved by inserting 
2 Controlled Internal Drug Release (CIDR) devices (Zoetis, Parsippany, NJ) sc and leaving these 
in place for 10-14 days. Previous studies in ewes demonstrated that sc implantation of CIDRs 
resulted in levels of plasma progesterone that were similar to vaginally inserted CIDRs (40–42).  
Blood samples (3–4 ml) were collected by venipuncture, placed in heparinized tubes and plasma 




Hypothalamic tissue blocks were collected for immunohistochemical analysis and for histological 
examination of guide cannula placements as previously described (39). Briefly, animals were 
treated with heparin (20,000 U) 10 minutes before and at the time of euthanasia, which was 
accomplished by an intravenous overdose of sodium pentobarbital (8 to 12 mL, Euthasol; Patterson 
Veterinary, Bessemer, AL). Once respiration stopped and there was no eye-blink reflex, the animal 
was exsanguinated by cutting the carotids, and the head rapidly removed and perfused via the 
carotid arteries with 4 L (lambs) or 6 L (adults) of a solution containing 4% paraformaldehyde in 
0.1 M phosphate buffer (PB) with 0.1% sodium nitrite. Tissue blocks containing the POA and 
hypothalamus were removed and stored overnight in fresh paraformaldehyde solution at 4°C. The 
following day, blocks were transferred to a solution containing 20% sucrose in 0.1M PB and stored 
at 4°C. A microtome with a freezing stage was used to section blocks in 45-μm increments. For 
the studies where galanin was injected or galantide was infused, every fifth section through the 
MBH was stained with cresyl violet and examined to determine if guide cannulas correctly targeted 
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the third ventricle. For the galanin/NK3R co-expression and tract-tracing studies, 10 parallel series 
of sections (450 μm apart) were stored in cryoprotectant (43) at −20°C.  
 
All procedures were approved by the West Virginia University Animal Care and Use Committee 
and were performed in accordance with the National Institutes of Health guidelines for the care 
and use of research animals. 
 
Experiment 1: Determine if galanin expression co-localizes with NK3R within the RCh and 
if these neurons project to the ARC. 
 
To characterize the expression of galanin and its co-localization with NK3R within the RCh, we 
used tissue from young wethers (n = 6) and acutely OVX female sheep (n = 5) that had received 
two sequential artificial luteal phases that had been collected for other studies (Chapter 2). Tissue 
was collected during an artificial follicular phase, 18-20 hours after insertion of four long estradiol 
implants. Blood samples were collected every 12 min for 2 hours immediately prior to tissue 
collection. To determine if galanin-containing neurons projected to the ARC, tissue was collected 




For detection of NK3R and galanin, dual-label immunohistochemistry was performed on a 
complete series of free-floating hemi-sections throughout the RCh from each animal. All washes 
were performed at room temperature under gentle agitation with phosphate-buffered saline (PBS). 
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Sections were rinsed 4 times for 5 minutes between incubations unless noted otherwise. On the 
first day, tissue sections were rinsed thoroughly 12 times at 15 minutes each. After PBS washes, 
tissue sections were incubated for 1 hour in 1% H2O2 for 10 minutes, rinsed, and incubated in 20% 
normal goat serum (NGS; Jackson Immunoresearch, West Groove, PA) in PBS containing 0.4% 
triton X-100 before overnight incubation with rabbit anti-porcine Galanin (1:500) (Phoenix, 
Catalog #H-026-06, Lot 01578-1) (PBST with 4% NGS). On the second day, sections were rinsed 
and then incubated in biotinylated goat anti-rabbit immunoglobin (1:500 in 4% NGS; Vector BA-
1000, Lot ZA0520) for 1 hour, followed by ABC-elite (1:500 in PBS; Vector Laboratory 
Burlingame, CA) for 1 hour. Sections were rinsed again and incubated for 10 minutes in 
biotinylated tyramine (TSA) (dilution 1:250; Perkin Elmer, Waltham, MA, USA) in PBS 
containing 3% H2O2 per 1 mL of solution. After rinsing, sections were incubated in DyLight green 
488-conjugated to streptavidin (1:100 in PBS; Fisher Scientific) for 30 minutes, followed by rinses 
and incubation for 1 hour in 4% NGS. Sections were incubated overnight with rabbit anti-NK3R 
(dilution 1:1,000 in 4% NGS; Novus, Catalog #NB300-102, Lot F1). On the third day, sections 
were rinsed and then incubated in Alexa555 goat anti‐rabbit (dilution 1:100 in 4% NGS; Life 
Technologies, Carlsbad, CA, USA) for 30 minutes. Sections were rinsed again before being 
incubated with Neurotrace 640/600 Deep Red Fluorescent Nissl Stain (1:100 in PBS; Life 
Technologies; Lot N21483) for 20 minutes. Sections were then rinsed in phosphate buffer (PB), 
mounted on charged Superfrost slides (Fisher Scientific), cover-slipped using Gelvatol and stored 




The procedure for dual immunohistochemistry of galanin and CT was identical to that for galanin 
and NK3R, except that rabbit anti-CTβ (1:1,000) (C3062; Sigma-Aldrich) (PBST with 4% NGS) 
was used rather than the antibody against NK3R. 
 
Analysis of NK3R and galanin immunoreactivity in the RCh:  
 
The total number of NK3R-ir and galanin cells in the RCh was assessed using an upright 
fluorescent microscope (VS120; Olympus, Tokyo, Japan) with a 20x objective. The total number 
of cells represents the sum of cell numbers in three representative RCh hemi-sections that extended 
in the lateral direction from the fornix to the medial edge of the optic tract, dorsally from the fornix 
to the base of the brain and approximately 1.4 mm (three hemi-sections) posterior to the optic 
chiasm (41,44,45). Galanin cell numbers and the percentage that colocalized with NK3R were 
totaled across 3 hemi-sections. All cell counts were made by an observer blinded to treatment 
groups.  
 
Analysis of CTβ and galanin immunoreactivity in the RCh: 
 
To examine CTβ and galanin immunoreactivity in the RCh, sections processed for dual-
immunofluorescence were captured across at least 2 sections per side of the RCh ipsilateral to 
injection for each animal using a Hamamatsu Orca Flash 4.0 monochrome cMOS camera on a 
Nikon A1R confocal microscope (Nikon Instruments Inc., Melville, NY) with a Plan Apochromat 
VC 60X Oil/1.4 WD (130 µm) objective. Confocal Z-stacks of optical sections were taken at 1 µm 
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intervals through image. CTβ and galanin immunoreactivity was visually analyzed using the 
Nikon software, NIS Elements.  
 
Experiment 2: Does galanin act in the hypothalamus to regulate tonic LH secretion in intact 
anestrous ewes?  
 
Six ovary-intact anestrous ewes received a permanent cannula into the third ventricle in mid-April 
(anestrous season). Ewes were randomly assigned to receive a single icv injection of galanin (2 
nmol in 150 μL sterile saline) or vehicle (150 μL sterile saline); this dose was selected as a 
conservative estimate per previous data in rodents and one report in sheep (26,46,47). Blood 
samples were collected every 12 min for a total of 6 hours; galanin or saline was injected icv after 
2 hours of sampling. The protocol was repeated one week later, at which time each animal received 
the alternate treatment in a crossover design. 
 
Experiment 3: Does galanin act in the hypothalamus to regulate tonic LH secretion in luteal 
phase ewes?  
 
Six ovary-intact ewes received a permanent cannula into the third ventricle in mid-October 
(breeding season). Estrous cycles were synchronized with 2 intramuscular injections of 
prostaglandin F2α (20 mg) (Lutalyse, Zoetis, Parsippany, NJ) given 7 days apart (48). Ten days 
after the second treatment with prostaglandin (day 8 of cycle, mid‐luteal phase), blood samples 
were collected every 12 min for 36 min and a single dose of galanin (0, 2, 5, 10 nmoles) was 
injected icv. Blood collection continued for 8 hours with a second, different dose given 4 hours 
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after the first injection. Doses were administered in a random order to control for carry‐over 
effects. Ewes were given prostaglandin the day after sampling and the protocol repeated on day 8 
of the next luteal phase, with each ewe receiving the two doses that she did not receive in the first 
replicate.  
 
Experiment 4: Effect of galantide on the LH surge during the breeding season  
 
Six breeding season ewes were ovariectomy (OVX) and received a permanent cannula into the 
third ventricle in mid-October (breeding season). Ewes received a single 1-cm estradiol implant 
and two CIDRs at time of OVX. Approximately 10‐14 days later, CIDRs were removed and the 
next day four, 3-cm estradiol implants were placed sc to induce a LH surge. The following day, 
ewes were restrained in their pen and a harness containing a pack for a battery‐operated pump 
strapped to their backs. Ewes were randomly assigned to receive either saline (60 L/hour) or 
galantide (15 nmoles/60 L/hour) infused into the third ventricle for 12 hours, starting 10 hours 
after insertion of estradiol-containing implants. This dose was chosen because we saw no effect of 
5 nmoles/60 L/hour galantide on the LH surge in a preliminary experiment during anestrus. 
Infusions lines, pumps, and packs were then removed and animals again allowed free movement 
in the pen. Blood samples were collected via jugular venipuncture every 4 hours for the first 8 
hours and then every 2 hours for the remaining 32 hours. After sampling, the four long estradiol 
implants were removed and two CIDRs inserted. This protocol was then repeated 10 days later 
using a cross-over design. 
 





Radioimmunoassays for LH were performed as previously described for ovine samples (49). 
Briefly, LH concentrations were measured in duplicate using 100 – 200 μL of plasma per sample 
via a double-antibody radioimmunoassay with reagents supplied by the National Hormone and 
Peptide Program (Torrance, CA, USA). The sensitivity of the assay averaged 0.06 ng/tube, and 




For Experiments 2 and 3, mean LH concentration, LH pulse frequency and LH pulse amplitude 
(maximal pulse value minus preceding nadir) were determined during the 4-hour post-injection 
sampling periods and analyzed by two-way analysis of variance (ANOVA) with repeated measures 
(time and treatment as main factors). Pulses were identified using established criteria (50). Briefly, 
a pulse had to be 2 assay standard deviations greater than the preceding nadir, the pulse had to 
occur within two samples of the preceding nadir, and the amplitude had to be greater than the assay 
sensitivity. Post-injection response time (time from injection to the first pulse) was compared 
between treatment groups with a paired t-test. The proportion of animals responding to galanin 
treatment within 1 hour was compared using Chi-Square analysis.  
 
For Experiment 4, the time to maximal LH secretion and the amplitude of the LH surge (maximal 
concentration minus LH concentration of the first sample collected at time of insertion of large 
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estradiol implants) were compared between treatment groups with paired t-tests. Data are reported 




Experiment 1: Determine if galanin co-localizes with NK3R within the RCh and if these 
neurons project to the ARC. 
 
As expected, mean LH concentrations were much higher in females compared to males at the time 
of tissue collection (97.9 ± 38.6 ng/mL vs 3.82 ± 0.61 ng/mL) and the number of NK3R-ir cells in 
the RCh was greater in females than in males (female 114.2 ± 18.9 vs male 83.8 ± 5.7 cells). 
Approximately 20% of these NK3R-ir neurons also contained galanin, although there was no 
difference between the sexes (female 21.8 ± 4.9 % vs male 25.1 ± 3.1 %; P = 0.60); a much larger 
percentage of galanin neurons contained NK3R, however this was also not sexually dimorphic: 
female 51.3 ± 6.7 % vs male 65.4 ± 5.4 % (P = 0.07).  The number of galanin-immunoreactive 
cells found within the RCh was also not sexually dimorphic: female 44 ± 7.3 cells vs male 32 ± 
4.2 cells (Fig. 4.1).  
 
Confocal analysis of fluorescence-stained sections confirmed that CTβ-immunoreactive neurons 
co-expressed galanin within the RCh (Fig. 4.2). From a qualitative perspective, neurons expressing 
CTβ were readily observed in the RCh on the ipsilateral side of CTβ injections in the ARC and 
some of these contained galanin, but this was not analyzed quantitatively. CTβ immunoreactivity 
was relatively low in the RCh on the contralateral side of the injection site, although some scattered 
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CTβ-immunoreactive neurons were occasionally observed. Galanin immunoreactivity was readily 
visualized on the contralateral side of the injection site.  
 
Experiment 2: Does galanin act in the hypothalamus to regulate tonic LH secretion in intact 
anestrous ewes?  
 
Administration of galanin to anestrous ewes had a tendency to increase LH pulse frequency 
compared to administration of saline: galanin, 1.7 ± 0.2 ng/mL versus saline, 1.0 ± 0.3 ng/mL, P 
= 0.07 (Fig. 4.3). Additionally, within 1 hour of galanin administration, at least one pulse was 
observed in all 6 animals. In comparison, at least one pulse was observed in only 3 animals in the 
hour following administration of saline (P = 0.02). Administration of galanin to anestrous ewes 
did not significantly affect LH pulse amplitude (galanin, 5.0 ± 1.6 ng/mL versus saline, 2.4 ± 0.7 
ng/mL, P = 0.19) or mean LH concentration (galanin, 1.7 ± 0.6 ng/mL versus saline, 1.3 ± 0.1 
ng/mL, P = 0.20) (Fig. 4.3).  
 
Experiment 3: Does galanin act in the hypothalamus to regulate tonic LH secretion in luteal 
phase ewes?  
 
Administration of a 5 nmol dose of galanin to luteal phase breeding season ewes had a modest 
effect on LH pulse amplitude compared to administration of saline: galanin (5 nmol), 2.3 ± 0.6 
ng/mL versus saline, 1.3 ± 0.1 ng/mL, P = 0.06 (Fig. 4.4). No effect of galanin at a dose of 2 or 10 
nmol was observed on LH pulse amplitude and no dose affected LH pulse frequency or mean LH 




Experiment 4: Effect of galantide on the LH surge during the breeding season  
Estradiol treatment resulted in LH surges during the infusion of saline in 5 out of 6 animals (# 133 
excluded). Administration of galantide did not result in a significant decrease in mean amplitude 
compared to saline (Fig. 4.5).  However, the reduction observed was approximately 25% and there 
was a clear decrease in LH surge amplitude in two ewes infused with galantide (# 131 and # 132) 
(Fig 4.5). In addition, there was no significant delay in the time to peak after galantide 




In the present study, we characterized the expression of galanin in the RCh, assessed the amount 
of colocalization between galanin and NK3R, and determined whether galanin neurons project to 
the ARC. Furthermore, we evaluated the effect of central administration of galanin on LH secretion 
in breeding season and anestrous ewes and galanin receptor blockade during an estrogen-induced 
LH surge. We demonstrated that galanin immunoreactivity in the RCh separately co-localized with 
NK3R and CTβ colocalization. These results provide neuroanatomical support for the hypothesis 
that galanin activity could potentially mediate the effects of NKB on the LH surge in sheep. 
Additionally, we found evidence for a minor stimulatory effect of galanin on LH pulse frequency 
during anestrous and LH pulse amplitude during the breeding season. During an estrogen-induced 
LH surge, we observed that blockade of galanin receptors by galantide infusion resulted in a minor 
inhibitory effect on surge amplitude (approximately by 25%; non-significant). In addition to our 
neuroanatomical findings, these results raise the possibility that endogenous galanin may 
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participate in the induction of the LH surge in sheep. However, further work is needed to more 
rigorously test this hypothesis before making any definitive statements about the role of galanin in 
LH secretion in ewes.  
 
In this study, we confirmed that the total number of NK3R-containing cells in the RCh was lower 
in males than females when tissue was collected in the presence of surge-inducing levels of 
estradiol. In contrast, no difference was observed in the number of galanin-immunoreactive cells 
found within the RCh between males and females. These results are similar to previous findings 
that galanin expression throughout the hypothalamus, as a whole, is not sexually dimorphic in 
sheep (8,28). This is also in contrast to what is observed in rodents, as galanin expression is found 
to be highly sexually dimorphic in both mice (51) and rats (16). One report observed a slightly 
stronger intensity of galanin staining in male compared to female sheep and suggested that this 
indicates a higher cellular content of galanin peptide (28), though assessing modest differences in 
staining intensity with immunocytochemistry is technically difficult. In this report, there was no 
noticeable difference in the intensity of galanin immunoreactivity between sexes (Lopez et al., 
unreported). To our knowledge, this is the first report to demonstrate galanin and NK3R 
colocalization in any species and represents a first report of the phenotype of a subpopulation of 
the NK3R-expressing neurons in the RCh. Only about 22% of the entire NK3R-containing cell 
population in this region co-expressed galanin and we did not find an effect of sex on the 
percentage of co-expression or number of galanin neurons.  The phenotype of the remaining NK3R 




CTβ was used to determine if galanin neurons located in the RCh project to the ARC. CTβ-
immunoreactive neurons were readily observed via confocal analysis in the RCh on the ipsilateral 
side of tissue collected from females with unilateral injections of CTβ in the ARC. This report is 
consistent with a previous tract-tracing study in which the anterograde tract tracer BDA was 
injected in the RCh. BDA-labelled axon terminals were observed in the ARC in close proximity 
to kisspeptin-immunoreactive soma and dendrites (35). In conjunction with our report, these 
findings provide evidence for a monosynaptic projection from RCh galanin neurons to ARC 
kisspeptin neurons and, thus, for a potential neuroanatomical circuit responsible for inducing a 
preovulatory LH surge in ewes (35,52).  
 
Despite the neuroanatomical evidence implicating galanin stimulation of LH release, central 
administration of galanin to anestrous or breeding season ewes only had modest effects on LH 
pulse frequency and amplitude, respectively. Although it was observed that all anestrous animals 
responded within 1 hour of administration of galanin, sustained LH release was not observed in 
either anestrus or during the breeding season. A couple of methodological considerations could 
account for the lack of sustained effects observed in this study: 1) method of delivery and 2) dose 
of galanin used. Because galanin was administered into the third ventricle, a specific site or sites 
of action cannot be ascertained. Given that galanin receptors are expressed throughout the POA 
and hypothalamus and affect numerous other neuroendocrine functions (28,47,53,54), more 
localized administration of galanin is likely necessary to potently effect sustained LH release. 
Furthermore, using a higher dose of galanin could have been more effective. The doses used in the 
studies herein are conservative and based on a previously-reported dose used to assess the effect 
of galanin administration on growth hormone concentrations (47). The doses used in our studies 
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may not be sufficient to produce consistent results. As such, injection of a higher dose of galanin 
in a more localized region may provide clearer insight regarding the involvement of galanin in 
ovine LH secretion.  
 
Although several lines of correlative evidence in sheep (as presented above and elsewhere) and 
pharmacological data in rodents (26) support a role for galanin in surge-type LH secretion, galanin 
receptor blockade with galantide administration did not significantly alter LH surge secretion in 
our experiments. As stated above, several methodological or theoretical considerations could 
account for the lack of effect of these drugs. A more effective concentration of galantide and more 
localized administration may be necessary to markedly affect surge secretion of LH. Notably, the 
maximum effect we have observed with disruptions of NKB-NK3R signaling in the RCh is a 50% 
decrease in amplitude of the surge (Goodman et al., 2018, International Congress of 
Neuroendocrinology Abstract) (34), so it might not be too surprising that we only reduced surge 
amplitude by 25%.  This would also be consistent with the fact that only ~20% of NK3R neurons 
in the RCh are galanin positive. Thus, the contribution of galanin to the surge may not be as robust 
as the entirety of the NK3R-containing population of neurons within the RCh. Additionally, 
several redundant systems contribute to the generation of the LH surge (5). Because of this, 
compensatory pathways could mask any effects caused by blocking the actions of galanin. During 
an estrogen-induced surge, galantide infusion collectively resulted in a relatively minor inhibitory 
effect on surge amplitude (approximately by 25%) and did not influence timing of the surge.  
However, in 2 of the 5 animals wherein galantide administration coincided with surge release, 
amplitude was reduced by approximately 50%. A similar degree of reduction in the amplitude of 
the LH surge has been shown after icv administration of both a Kiss1r antagonist (55) and NK3R 
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antagonist (34). These findings raise the possibility that galanin may be acting on the same 
populations of neurons that are affected in these previous studies. Additionally, neither the NK3R 
nor Kiss1r antagonist altered the timing of the surge. As such, the lack of an effect of galantide on 
this variable was not surprising (34,55). 
 
In summary, we demonstrated that galanin/NK3R colocalization in the RCh exists to the same 
degree in both males and females. We further showed that galanin and CTβ colocalize in the RCh 
following injection of CTβ in the ARC.  Thus, NKB may stimulate NK3R-containing galanin 
neurons in the RCh that project to the ARC to stimulate kisspeptin release from KNDy neurons 
and, in this way, is important for normal LH surge generation. At this time, there is limited 
pharmacological data supporting this hypothesis, because only modest effects were observed with 
galanin on tonic LH secretion and galanin receptor blockade on LH surge generation.  Thus, further 
studies are needed to more completely test the possible role of RCh NK3R and galanin-containing 
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Figure Legends  
 
Figure 4.1. Galanin and NK3R immunoreactivity in the RCh of female and male sheep. Top and 
bottom panels present low- and high-magnification images illustrating galanin (red 
immunoreactivity), NK3R (green) immunoreactivity, and Nissl staining (blue) in the RCh of a 
female and male sheep, respectively. Higher magnification images of areas identified by the 
dashed, white boxes are presented in inset images. Scale bars: standard image = 100 µm; inset 
image = 50 µm. Arrows indicate some galanin (yellow), NK3R (white), and colocalized (red) cells. 
 
Figure 4.2. Galanin- and CTβ-immunoreactivity in the RCh of female sheep. Representative 
images illustrating galanin (green) and CTβ (red) in the RCh ipsilateral and contralateral to 
injections of CTβ into one hemisphere of the ARC. Red arrows represent CTβ neurons, green 
arrows represent galanin neurons, and yellow arrows represent colocalization between CTβ and 
galanin. Scale bar = 50 µm.  
 
Figure 4.3. Effect of icv injection of galanin (2 nmol) or saline on LH secretion in ovary-intact 
anestrous ewes (n = 6). (A) LH concentration patterns in all animals for the entire 6-hour sampling 
period (open circle, saline; closed circles, galanin). Pulses are denoted by red (galanin) or blue 
(saline) circles. (B) Mean LH concentrations (± SEM) post-injection of saline (white bars) or 
galanin (black bars). (C) Mean Pulse Frequency (± SEM) represents the number of pulses for the 
4-hour sampling period post-injection of saline (white bars) or galanin (black bars). (D) Mean 
Pulse Amplitude (± SEM) for the 4-hour sampling period post-injection of saline (white bars) or 




Figure 4.4. Effect of icv injection of galanin or saline on LH secretion in ovary‐intact breeding 
season ewes (n=6) synchronized with prostaglandin. (A) LH concentration patterns in 2 
representative animals for the entire 8-hour sampling period (green line, Day 1; blue line, Day 2). 
Doses are listed in the order in which they were received and the color that corresponds to the day 
of treatment (e.g., green, 2  5 = 2 nm dose (4 hours) followed by a 5 nm dose (4 hours) on Day 
1). Pulses are denoted by open circles. (B) Mean LH concentrations (± SEM) pre-injection (white) 
or post-injection of galanin at 0 (saline), 2, 5, or 10 nm doses (corresponding gray and black bars). 
(C) Mean Pulse Frequency (± SEM) represents the number of pulses for the 4-hour sampling 
period post-injection of galanin at 0 (saline), 2, 5, or 10 nm doses (corresponding gray and black 
bars). (D) Mean Pulse Amplitude (± SEM) for the 4-hour sampling period post-injection of galanin 
at 0 (saline), 2, 5, or 10 nm doses (corresponding gray and black bars).   
 
Figure 4.5.  Effect of galantide (red) and saline (black) on the estrogen-induced LH surge during 
the breeding season. LH concentrations during estradiol-induced LH surges in all animals. Black 
bar is representative of the infusion period. Right panel: LH surge amplitude (galantide, black bars; 
saline, white bars), time (hours after estradiol implants) of maximum LH value (galantide, black 









































































Figure 4.4.  
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Figure 4.5.  
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Morphological and Functional Evidence of Sexual Dimorphism in the Retrochiasmatic 































GENERAL DISCUSSION  
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The preceding chapters describe functional and morphological data collected to test the hypothesis 
that NK3R activity in the RCh contributes to the control of the LH surge in sheep. In addition, 
morphological and functional evidence has been provided to test the role of RCh galanin neurons, 
which represent a subset of the entire RCh NK3R population, in affecting LH secretion.  
 
1. NKB-NK3R Activity and the LH Surge  
 
Several lines of evidence described in Chapter 2 led to the hypothesis that NKB-NK3R signaling 
in the RCh contributes to the LH surge in ewes (1–4). In this report, we observed differences in 
the patterns of LH release in response to RCh senktide administration between males and females 
(Chapter 2). LH release following administration of senktide in the RCh was elevated and 
prolonged in females. This pattern of LH secretion is typical of an LH surge, which lasts 
approximately 12 hours in sheep (5), and supports the hypothesis that NKB activity within the 
RCh is important for the LH surge in females. In contrast, while increased LH release was clearly 
evident in males, this elevation was transient, lasting only about 2 hours. This led us to propose 
that the number of NK3R-ir neurons residing within the RCh is more numerous in females than in 
males. If this is the case, this population would be expected to be more readily activated and able 
to respond for a longer period in females. The more prolonged response in females may also be 
due to a greater number of KNDy neurons in the ARC of females because activation of RCh 
NK3R-containing cells acts through ARC kisspeptin release to influence LH secretion (3).  
Regardless, the temporal differences between the sexes in response to senktide provide functional 




2. NKB-NK3R Expression in the POA and RCh of Male and Female Sheep  
 
The discovery of sexual differences in the number of NK3R-containing cells in the POA and RCh 
supports the possibility that NK3R-containing neurons in these areas may contribute to the LH 
surge, as discussed above. In Chapter 2, the total number of NK3R-containing cells in the POA 
was lower in wethers compared to ewes. However, in acutely castrated males, the total number of 
NK3R-containing cells in in the POA did not differ between sexes after surge-inducing levels of 
estradiol (Chapter 3). This finding is in agreement with what was observed in prenatal-
testosterone-treated females (6). One simple explanation for the discrepancy between our two 
studies is that the prolonged absence of androgens results in decreased NK3R expression in 
wethers. However, the difference between these two studies may reflect differences in the number 
of NK3R-ir cells observed in females, rather than differences observed in males, as previously 
discussed (Chapter 3). Still, the observation that no difference appears in the number of POA 
NK3R-containing cells between acutely castrated males and females may not be too surprising 
given two lines of evidence that endogenous NKB may not act in the POA to induce an LH surge. 
First, administration of a NK3R antagonist into the POA did not alter the timing or amplitude of a 
LH surge induced with estradiol (2). Second, there was no change in the percent of NK3R cells in 
the POA that expressed c-Fos during the LH surge compared to the luteal or early follicular phase 
of the estrous cycle (McCosh et al., unpublished).  
 
The total number of NK3R-containing cells in the RCh was lower in both wethers and acutely-
castrated rams compared to females in tissue collected in the presence of surge-inducing levels of 
estradiol (Chapter 2 and 3). This differs from what is found in prenatal testosterone-treated females 
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(6), in which no effect of testosterone treatment on the number of NK3R-containing cells was 
found in the RCh. This is likely the result of differences in animal models because females born 
to testosterone-treated mothers still exhibit some aspects of female reproductive function, 
including a blunted LH surge, for at least two years after birth (7,8). In addition to differences in 
the number of NK3R-containing neurons, we also observed dramatic sex differences in the 
quantity of NKB-ir fibers and NKB-containing inputs onto NK3R-ir cells in the RCh (Chapter 2). 
The presence of NKB-containing fibers in the RCh is in agreement with previous findings in 
female sheep (9). However, the origin of these fibers remains unknown. In sheep, nearly all NKB-
ir neurons are located in the ARC (10,11), and the vast majority of these neurons also contain 
kisspeptin (12). However, these KNDy neurons do not project to the RCh because few, if any, 
kisspeptin-ir fibers are seen in this region (13). Thus, we concluded that the source of the NKB 
inputs seen in the RCh could be either the small number of NKB neurons in the ARC that do not 
co-express kisspeptin (12) or other NKB-producing cells that cannot be detected by 
immunohistochemistry because the peptide is rapidly transported to terminals.  
 
 
3. NKB, Kisspeptin, and NK3R Expression in the ARC of Male and Female Sheep  
 
The observation that the number of NKB cells in the ARC is higher in young females compared 
to young males (wethers and acutely-castrated rams) is in agreement with previous results in young 
and adult intact rams (10,14) and prenatally testosterone-treated females (6). The number of 
kisspeptin cells in the ARC was also higher in steroid-treated gonadectomized females compared 
to males in Chapter 3. This is in agreement with earlier reports in adult, gonadally-intact sheep 
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(15). In contrast, kisspeptin cell numbers in the ARC are not affected by testosterone treatment in 
utero because androgenized females do not show reduced levels compared to normal females when 
tissue is collected during an “artificial follicular phase” (16). The latter observations raised the 
possibility that the sexual dimorphism seen in gonadally-intact sheep was due to differences in the 
endogenous hormonal milieu, not the organizational actions of androgens in utero. Tissue in this 
study was collected during an artificial follicular phase, and because of this, differences in 
kisspeptin expression cannot be due to differences in endogenous steroid concentrations and thus 
most likely reflect the organizational actions of androgens.  There are two possible explanations 
for the absence of this sexual dimorphism in prenatally androgenized ewes. The simpler of the two 
is that more prolonged exposure to androgen in utero may be required. Alternately, post-natal 
exposure to estradiol may play a role. Postnatal exposure to the ovaries or exogenous estradiol is 
required for prenatally testosterone-treated females to undergo complete defeminization of the 
GnRH surge mechanism (17). Thus the possibility exists that during this additional period of 
“differentiation,” postnatal exposure to estrogen, rather than testicular testosterone, within the first 










Figure 5.1. Schematic representation of connectivity between neurons implicated in the 




Figure 5.1. NK3R-containing neurons (grey), a percentage of which contain galanin (orange), in 
the RCh project to KNDy neurons in the ARC.  KNDy neurons coexpress kisspeptin (green), NKB 
(purple), and dynorphin (not illustrated) and innervate kisspeptin (green) and GnRH neurons (blue) 
neurons in the POA. The source of NKB that activates NK3R-containing neurons in the RCh is 
currently unknown. Expression of NK3R (grey) and NKB (purple) in the RCh and KNDy cells 
(purple/green) in the ARC are reduced in males.  ac, anterior commissure; inf, infundibular recess; 







The decreased NKB/NK3R signaling found in males may contribute to the sexual dimorphism in 
both the response to senktide and the failure of males to produce GnRH/LH surges. The decreased 
number of NK3R-containing neurons in the RCh of males provides one simple explanation for the 
attenuated LH response to local administration of senktide observed in Chapter 2. These findings 
also support the hypothesis that the population of NK3R-containing cells in the RCh is necessary 
for full expression of the LH surge in females (2). These cells are thought to increase GnRH/LH 
secretion during a surge by activating release of kisspeptin from KNDy cells in the ARC (3). Thus, 
the lower number of KNDy cells in the ARC of males could also contribute to the sexual 
dimorphism seen in the inability of males to generate an LH surge. However, the ability of senktide 
to increase LH secretion in males indicates that the difference in NK3R expression in the RCh and 
KNDy cell numbers in the ARC cannot account, by themselves, for the lack of an estrogen-induced 
LH surge. Thus, one can infer that the decrease in NKB input to this region in males likely 
contributes to the sexual dimorphism in estrogen positive feedback in sheep.  
 
 
4. Galanin Expression in the RCh of Sheep  
 
As previously discussed, the phenotype of NK3R-containing neurons in the RCh has yet to be 
elucidated. Based on its anatomical distribution in sheep, we hypothesized that one potential 
neurotransmitter is galanin. Per our initial observations, we found that galanin-ir cells were readily 
visualized throughout the POA and hypothalamus (Lopez et al., unreported observations). 
However, no difference was observed in the number of galanin-immunoreactive cells found within 
the RCh between males and females (Chapter 4). This finding does not agree with the hypothesis 
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that sexual dimorphism exists in the population of galanin neurons in the RCh. However, it could 
be possible that sexual dimorphism exits in neurons upstream of galanin, i.e., NKB as discussed 
in Chapter 2, and those effects are translated through galanin. Regardless, these results are similar 
to previous findings that galanin expression throughout the hypothalamus, as a whole, is not 
sexually dimorphic in sheep (18,19). This is also in contrast to what is observed in rodents, as 
galanin expression is found to be highly sexually dimorphic in both mice (20) and rats (21). To 
our knowledge, this is the first report to demonstrate galanin and NK3R colocalization in any 
species, although no differences were observed in the percentage of galanin/NK3R co-expression 
between sexes. Furthermore, CTβ-immunoreactive neurons were readily observed in the RCh from 
females with unilateral injections of CTβ in the ARC. A portion of these CTβ-positive neurons co-
expressed galanin.  These findings support galanin as a candidate for the previously unknown 
phenotype of NK3R-containing cells in the RCh that project to ARC kisspeptin neurons and 
provide a potential neuroanatomical circuit responsible for inducing a preovulatory LH surge in 
ewes (3,4). Only about 22% of the entire NK3R-containing cell population in this region also 
contain galanin, but it is unknown what percentage of NK3R neurons in this region are dedicated 
to the LH surge. 
 
5. Galanin Activity and LH Secretion  
 
Despite a neuroanatomical basis implicating galanin in stimulating LH release, central 
administration of galanin to anestrous or breeding season ewes only had modest effects on LH 
pulse frequency and amplitude, respectively. Although it was observed that all anestrous animals 
responded within 1 hour of administration of galanin, sustained LH release was not observed in 
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either anestrus or during the breeding season.  Additionally, several lines of correlative evidence 
in sheep (as presented above and elsewhere), and pharmacological data in rodents (22), support a 
role for galanin in surge-type LH secretion. However, galantide administration did not 
significantly alter surge secretion in our experiments. Several methodological or theoretical 
considerations could account for the lack of effect of these drugs in both sets of experiments as 
discussed in Chapter 4. First, a more effective concentration of galanin or galantide and more 
localized administration may be necessary to markedly affect surge secretion of LH. The 
maximum effect we have observed with disruptions of NKB-NK3R signaling in the RCh is a 50% 
decrease in amplitude of the surge (2) (Goodman et al., 2018, International Congress of 
Neuroendocrinology Abstract), so this might be the upper limit of the effects of blocking galanin 
action in that experiment. Additionally, several redundant systems contribute to the generation of 
the LH surge (23). Therefore, compensatory pathways could mask any effects caused by altering 
the effects of galanin. During an estrogen-induced surge, galantide infusion resulted in a minor 
inhibitory effect on surge amplitude (approximately by 25%) and in 2 of the 5 animals infused, 
galantide administration reduced surge amplitude by approximately 50%. A similar degree of 
reduction in the amplitude of the LH surge has been shown after icv administration of both a Kiss1r 
antagonist (24) and NK3R antagonist (2). These findings raise the possibility that the infusion of 
galantide may be acting on the same populations of neurons that are affected in these previous 
studies. Additionally, neither the NK3R nor Kiss1r antagonist altered the timing of the surge. As 
such, the lack of an effect of galantide on this variable is not surprising (2,24). 
 




In this work, we have demonstrated morphological and functional evidence of sexual dimorphism 
in NKB-NK3R signaling in the ovine RCh. Senktide administration in the RCh resulted in 
prolonged, surge-like LH release in female, but not male sheep. This finding is associated with 
fewer NK3R-positive cells and NKB contacts onto NK3R-containing cells in the RCh, and fewer 
NKB and kisspeptin cells in the ARC of males. These findings led us to conclude that deficiencies 
in NKB inputs to the RCh, the response to NKB in the RCh, and in the ability of KNDy neurons 
to respond to a stimulus from the RCh all contribute to the sex-dependent expression of the 
GnRH/LH surge in sheep. Additionally, we provide evidence for the existence of galanin/NK3R 
colocalization in the RCh in females and thus support a role for galanin as a possible candidate for 
the neurotransmitter in NK3R-containing cells needed for the LH surge in this region. Based on 
the observation that galanin and CTβ colocalize in the RCh, NKB may stimulate NK3R-containing 
galanin neurons in the RCh that project to the ARC to stimulate kisspeptin release from KNDy 
neurons.  
 
Further work is needed to adequately test this model.  One major question that remains is which 
population of NKB neurons project to the RCh. This question could be tested by injecting 
retrograde tract tracer Fluorogold into the RCh in ovary-intact ewes. The distribution of these cells 
can be identified with in situ hybridization and determined to project to the RCh if Fluorogold co-
expression is observed. Furthermore, triple-label immunohistochemistry is necessary to test if the 
population of galanin neurons that co-express CTβ also contain NK3R.Only a percentage of NK3R 
neurons contain galanin, and vice-versa; thus, it is difficult to determine whether the galanin 
neurons that contain CTβ are those that coexpress NK3R without additional testing. As previously 
mentioned, testing if the population of galanin neurons that coexpress NK3R also receive NKB 
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inputs would be beneficial. The experiment could be performed as previously described (Chapter 
2), and the findings from this study could explain why sex differences in galanin cell number are 
not observed in the RCh. In our functional studies, administration of senktide-containing 
microimplants in the RCh should be performed in acutely gonadectomized males and females as 
described in Chapter 2. As discussed in the preceding chapters, LH was not suppressed in wethers 
to a level that was comparable to females while, in acutely castrated rams, a similar amount of 
suppression was accomplished. Thus, this model presents a more direct comparison between sexes. 
Lastly, a more effective concentration of galanin or galantide and/or more localized administration 
of each peptide may be necessary to markedly affect LH secretion in ewes, as seen in rodents.  
Additional testing should be performed to more rigorously test this hypothesis before making any 
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